View Filing Data

Document And Entity Information - shares	9 Months Ended
Document And Entity Information - shares	Sep. 30, 2011	Nov. 07, 2011
Entity Registrant Name	MEDICAL PROPERTIES TRUST INC
Entity Central Index Key	0001287865
Document Type	10-Q
Document Period End Date	Sep. 30, 2011
Amendment Flag	false
Document Fiscal Year Focus	2011
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		111,700,249
MPT Operating Partnership L.P. [Member]
Entity Registrant Name	MPT Operating Partnership, L.P.
Entity Central Index Key	0001524607
Document Type	10-Q
Document Period End Date	Sep. 30, 2011
Amendment Flag	false
Document Fiscal Year Focus	2011
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2011	Dec. 31, 2010
Real estate assets
Land, buildings and improvements, and intangible lease assets	$ 1,258,288	$ 1,032,369
Mortgage loans	165,000	165,000
Gross investment in real estate assets	1,423,288	1,197,369
Accumulated depreciation and amortization	(100,772)	(76,094)
Net investment in real estate assets	1,322,516	1,121,275
Cash and cash equivalents	114,368	98,408
Interest and rent receivable	28,822	26,176
Straight-line rent receivable	34,603	28,912
Other loans	56,131	50,985
Other assets	39,249	23,058
Total Assets	1,595,689	1,348,814
Liabilities
Debt, net	649,013	369,970
Accounts payable and accrued expenses	57,666	35,974
Deferred revenue	23,576	23,137
Lease deposits and other obligations to tenants	27,770	20,157
Total liabilities	758,025	449,238
Equity
Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding
Common stock, $0.001 par value. Authorized 150,000 shares; issued and outstanding - 110,647 shares at September 30, 2011, and 110,225 shares at December 31, 2010	111	110
Additional paid in capital	1,054,040	1,051,785
Distributions in excess of net income	(204,343)	(148,530)
Accumulated other comprehensive loss	(11,982)	(3,641)
Treasury shares, at cost	(262)	(262)
Total Medical Properties Trust, Inc. stockholders' equity	837,564	899,462
Non-controlling interests	100	114
Total equity	837,664	899,576
Total Liabilities and Equity	1,595,689	1,348,814
MPT Operating Partnership L.P. [Member]
Real estate assets
Land, buildings and improvements, and intangible lease assets	1,258,288	1,032,369
Mortgage loans	165,000	165,000
Gross investment in real estate assets	1,423,288	1,197,369
Accumulated depreciation and amortization	(100,772)	(76,094)
Net investment in real estate assets	1,322,516	1,121,275
Cash and cash equivalents	114,368	98,408
Interest and rent receivable	28,822	26,176
Straight-line rent receivable	34,603	28,912
Other loans	56,131	50,985
Other assets	39,249	23,058
Total Assets	1,595,689	1,348,814
Liabilities
Debt, net	649,013	369,970
Accounts payable and accrued expenses	35,308	13,658
Deferred revenue	23,576	23,137
Lease deposits and other obligations to tenants	27,770	20,157
Payable due to Medical Properties Trust, Inc.	21,923	21,943
Total liabilities	757,590	448,865
Equity
General Partner - issued and outstanding - 1,106 units at September 30, 2011 and 1,102 units at December 31, 2010	8,500	9,035
Accumulated other comprehensive loss	(11,982)	(3,641)
Total MPT Operating Partnership capital	837,999	899,835
Non-controlling interests	100	114
Total capital	838,099	899,949
Total Liabilities and Equity	1,595,689	1,348,814
MPT Operating Partnership L.P. [Member] \| Common Units [Member]
Equity
Limited Partners Capital	841,481	894,441
MPT Operating Partnership L.P. [Member] \| LTIP Units [Member]
Equity
Limited Partners Capital

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2011	Dec. 31, 2010
Equity
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares issued	110,647,000	110,225,000
Common stock, shares outstanding	110,647,000	110,225,000
MPT Operating Partnership L.P. [Member]
Equity
General Partner, units issued	1,106,000	1,102,000
General Partner, units outstanding	1,106,000	1,102,000
MPT Operating Partnership L.P. [Member] \| Common Units [Member]
Equity
Limited Partners, units issued	109,541,000	109,123,000
Limited Partners, units outstanding	109,541,000	109,123,000
MPT Operating Partnership L.P. [Member] \| LTIP Units [Member]
Equity
Limited Partners, units issued	94,000	94,000
Limited Partners, units outstanding	94,000	94,000

Condensed Consolidated Statements Of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Revenues
Rent billed	$ 30,738	$ 23,472	$ 88,519	$ 69,032
Straight-line rent	1,802	(1,124)	5,606	469
Interest and fee income	5,251	6,296	15,812	20,594
Total revenues	37,791	28,644	109,937	90,095
Expenses
Real estate depreciation and amortization	8,430	6,209	24,678	18,100
Impairment charge			564	12,000
Property-related	312	600	629	2,055
General and administrative	5,736	5,849	20,428	20,532
Acquisition expenses	530	364	3,186	1,314
Total operating expenses	15,008	13,022	49,485	54,001
Operating income	22,783	15,622	60,452	36,094
Other income (expense)
Interest income and other	51	1,475	58	1,488
Debt refinancing costs	(10,425)	(342)	(14,214)	(6,556)
Interest expense	(11,935)	(8,092)	(32,462)	(26,106)
Net other expense	(22,309)	(6,959)	(46,618)	(31,174)
Income from continuing operations	474	8,663	13,834	4,920
Income (loss) from discontinued operations	(6)	301	141	7,463
Net income	468	8,964	13,975	12,383
Net income attributable to non-controlling interests	(43)	(45)	(131)	(63)
Net income attributable to MPT common stockholders/Operating Partnership partners	$ 425	$ 8,919	$ 13,844	$ 12,320
Earnings per common share/units - basic and diluted
Income from continuing operations attributable to MPT common stockholders/Operating Partnership partners		$ 0.08	$ 0.12	$ 0.04
Income from discontinued operations attributable to MPT common stockholders/Operating Partnership partners				0.08
Net income attributable to MPT common stockholders/Operating Partnership partners		$ 0.08	$ 0.12	$ 0.12
Weighted average shares/units outstanding:
Basic	110,714	110,046	110,568	97,573
Diluted	110,719	110,046	110,576	97,575
Dividends declared per common share/unit	$ 0.20	$ 0.20	$ 0.60	$ 0.60
MPT Operating Partnership L.P. [Member]
Revenues
Rent billed	$ 30,738	$ 23,472	$ 88,519	$ 69,032
Straight-line rent	1,802	(1,124)	5,606	469
Interest and fee income	5,251	6,296	15,812	20,594
Total revenues	37,791	28,644	109,937	90,095
Expenses
Real estate depreciation and amortization	8,430	6,209	24,678	18,100
Impairment charge			564	12,000
Property-related	312	600	629	2,055
General and administrative	5,718	5,858	20,366	20,458
Acquisition expenses	530	364	3,186	1,314
Total operating expenses	14,990	13,031	49,423	53,927
Operating income	22,801	15,613	60,514	36,168
Other income (expense)
Interest income and other	51	1,475	58	1,488
Debt refinancing costs	(10,425)	(342)	(14,214)	(6,556)
Interest expense	(11,935)	(8,092)	(32,462)	(26,106)
Net other expense	(22,309)	(6,959)	(46,618)	(31,174)
Income from continuing operations	492	8,654	13,896	4,994
Income (loss) from discontinued operations	(6)	301	141	7,463
Net income	486	8,955	14,037	12,457
Net income attributable to non-controlling interests	(43)	(45)	(131)	(63)
Net income attributable to MPT common stockholders/Operating Partnership partners	$ 443	$ 8,910	$ 13,906	$ 12,394
Earnings per common share/units - basic and diluted
Income from continuing operations attributable to MPT common stockholders/Operating Partnership partners		$ 0.08	$ 0.12	$ 0.04
Income from discontinued operations attributable to MPT common stockholders/Operating Partnership partners				0.08
Net income attributable to MPT common stockholders/Operating Partnership partners		$ 0.08	$ 0.12	$ 0.12
Weighted average shares/units outstanding:
Basic	110,714	110,046	110,568	97,573
Diluted	110,719	110,046	110,576	97,575
Dividends declared per common share/unit	$ 0.20	$ 0.20	$ 0.60	$ 0.60

Condensed Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010	Dec. 31, 2010
Operating activities
Net income	$ 468	$ 8,964	$ 13,975	$ 12,383
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization			25,254	19,634
Straight-line rent revenue			(5,606)	(587)
Share/Unit-based compensation			5,293	5,250
Gain on sale of real estate			(5)	(7,693)
Impairment			564	12,000
Increase (decrease) in accounts payable and accrued liabilities			13,317	2,899
Amortization and write-off of deferred financing costs and debt discount			8,523	4,961
Premium paid on extinguishment of debt			13,091	3,834
Other adjustments			(7,278)	(5,188)
Net cash provided by operating activities			67,128	47,493
Investing activities
Real estate acquired			(196,511)	(73,851)
Principal received on loans receivable			2,898	46,532
Proceeds from sale of real estate				75,000
Investment in loans receivable and other investments			(16,800)	(9,626)
Construction in progress and other			(12,297)	(15,578)
Net cash (used for) provided by investing activities			(222,710)	22,477
Financing activities
Revolving credit facilities, net			39,600	(137,200)
Additions to term debt			450,000	148,500
Payments of term debt			(237,810)	(216,325)
Distributions paid			(67,194)	(54,761)
Sale of common stock/units, net				288,470
Lease deposits and other obligations to tenants			7,613	2,233
Debt issuance costs paid and other financing activities			(20,667)	(9,713)
Net cash provided by financing activities			171,542	21,204
Increase in cash and cash equivalents for period			15,960	91,174
Cash and cash equivalents at beginning of period			98,408	15,307	$ 15,307
Cash and cash equivalents at end of period	114,368	106,481	114,368	106,481	98,408
Interest paid			18,761	20,846
Supplemental schedule of non-cash investing activities:
Real estate acquired via assumption of mortgage loan			(14,592)
Supplemental schedule of non-cash financing activities:
Distributions declared, unpaid	22,407	22,326	22,407	22,326
Assumption of mortgage loan (as part of real estate acquired)			14,592
MPT Operating Partnership L.P. [Member]
Operating activities
Net income	486	8,955	14,037	12,457
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization			25,254	19,634
Straight-line rent revenue			(5,606)	(587)
Share/Unit-based compensation			5,293	5,250
Gain on sale of real estate			(5)	(7,693)
Impairment			564	12,000
Increase (decrease) in accounts payable and accrued liabilities			13,254	2,825
Amortization and write-off of deferred financing costs and debt discount			8,523	4,961
Premium paid on extinguishment of debt			13,091	3,834
Other adjustments			(7,277)	(5,188)
Net cash provided by operating activities			67,128	47,493
Investing activities
Real estate acquired			(196,511)	(73,851)
Principal received on loans receivable			2,898	46,532
Proceeds from sale of real estate				75,000
Investment in loans receivable and other investments			(16,800)	(9,626)
Construction in progress and other			(12,297)	(15,578)
Net cash (used for) provided by investing activities			(222,710)	22,477
Financing activities
Revolving credit facilities, net			39,600	(137,200)
Additions to term debt			450,000	148,500
Payments of term debt			(237,810)	(216,325)
Distributions paid			(67,194)	(54,761)
Sale of common stock/units, net				288,470
Lease deposits and other obligations to tenants			7,613	2,233
Debt issuance costs paid and other financing activities			(20,667)	(9,713)
Net cash provided by financing activities			171,542	21,204
Increase in cash and cash equivalents for period			15,960	91,174
Cash and cash equivalents at beginning of period			98,408	15,307	15,307
Cash and cash equivalents at end of period	114,368	106,481	114,368	106,481	$ 98,408
Interest paid			18,761	20,846
Supplemental schedule of non-cash investing activities:
Real estate acquired via assumption of mortgage loan			(14,592)
Supplemental schedule of non-cash financing activities:
Distributions declared, unpaid	$ 22,407	$ 22,326	22,407	$ 22,326
Assumption of mortgage loan (as part of real estate acquired)			$ 14,592

Organization

9 Months Ended

Sep. 30, 2011

Organization [Abstract]

Organization

1. Organization

Medical Properties Trust, Inc., a Maryland corporation, was formed on August 27, 2003 under the General Corporation Law of Maryland for the purpose of engaging in the business of investing in, owning, and leasing commercial real estate. Our operating partnership subsidiary, MPT Operating Partnership, L.P. (the "Operating Partnership"), through which we conduct all of our operations, was formed in September 2003. Through another wholly-owned subsidiary, Medical Properties Trust, LLC, we are the sole general partner of the Operating Partnership. At present, we directly own substantially all of the limited partnership interests in the Operating Partnership and have elected to report our required disclosures and that of the Operating Partnership on a combined basis except where material differences exist.

We have operated as a real estate investment trust ("REIT") since April 6, 2004, and accordingly, elected REIT status upon the filing in September 2005 of the calendar year 2004 federal income tax return. Accordingly, we will not be subject to U.S. federal income tax, provided that we continue to qualify as a REIT and our distributions to our stockholders equal or exceed our taxable income. Certain activities we undertake must be conducted by entities which we elected to be treated as a taxable REIT subsidiaries ("TRS"). Our TRSs are subject to both federal and state income taxes.

Our primary business strategy is to acquire and develop real estate and improvements, primarily for long-term lease to providers of healthcare services such as operators of general acute care hospitals, inpatient physical rehabilitation hospitals, long-term acute care hospitals, surgery centers, centers for treatment of specific conditions such as cardiac, pulmonary, cancer, and neurological hospitals, and other healthcare-oriented facilities. We manage our business as a single business segment.

- Definition

The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 2-6
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Name Statement of Position (SOP)
-Publisher AICPA
-Number 94-6
-Paragraph 10
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Name FASB Interpretation (FIN)
-Publisher FASB
-Number 46R
-Paragraph 4, 14, 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6359553&loc=d3e288-107754

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2197480

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6921930&loc=d3e5614-111684

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 915
-SubTopic 235
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6472506&loc=d3e38932-110933

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2209116

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 272
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6970148&loc=SL6228881-111685

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2122150

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 720
-SubTopic 15
-URI http://asc.fasb.org/subtopic&trid=2122524

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2134480

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Staff Position (FSP)
-Number FAS140-4/FIN46(R)-8
-Paragraph 8, C1, C7
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Summary Of Significant Accounting Policies

9 Months Ended

Sep. 30, 2011

Summary Of Significant Accounting Policies [Abstract]

Summary Of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Unaudited Interim Condensed Consolidated Financial Statements: The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information, including rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine month periods ended September 30, 2011 are not necessarily indicative of the results that may be expected for the year ending December 31, 2011. The condensed consolidated balance sheet at December 31, 2010 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.

For information about significant accounting policies, refer to the consolidated financial statements and footnotes thereto included in our Annual Report on Form 10-K, as amended, for the year ended December 31, 2010 along with updates (if needed) provided in our Form 10-Qs filed in 2011.

Real Estate And Lending Activities

9 Months Ended

Sep. 30, 2011

Real Estate And Lending Activities [Abstract]

Real Estate And Lending Activities

3. Real Estate and Lending Activities

Acquisitions

On January 4, 2011, we acquired the real estate of the 19-bed, 4-year old Gilbert Hospital in a suburb of Phoenix, Arizona area for $17.1 million. Gilbert Hospital is operated by affiliates of Visionary Health, LLC, the same group that we expect will also operate the hospital that we are currently developing in Florence, Arizona. We acquired this asset subject to an existing lease that expires in May 2022.

On January 31, 2011, we acquired for $23.5 million the real estate of the 60-bed Atrium Medical Center at Corinth in the Dallas area, a long-term acute care hospital that was completed in 2009 and is subject to a lease that expires in June 2024. In addition, through one of our affiliates, we invested $1.3 million to acquire approximately 19% of a joint venture arrangement with an affiliate of Vibra Healthcare, LLC ("Vibra") that will manage and has acquired a 51% interest in the operations of the facility. We also made a $5.2 million working capital loan to the joint venture. The former operators of the hospital, comprised primarily of local physicians, retained ownership of 49% of the operating entity.

On February 4, 2011, we purchased for $58 million the real estate of Bayonne Medical Center, a 6-story, 278-bed acute care hospital in the New Jersey area of metropolitan New York, and leased the facility to the operator under a 15-year lease, with six 5-year extension options. The operator is an affiliate of a private hospital operating company that acquired the hospital in 2008.

On February 9, 2011, we acquired the real estate of the 306-bed Alvarado Hospital in San Diego, California for $70 million from Prime Healthcare Services, Inc. ("Prime"). Prime is the operator of the facility and will lease the facility under a 10-year lease that provides, under certain conditions for lease extensions.

On February 14, 2011, we completed the acquisition of the Northland LTACH Hospital located in Kansas City, a 35-bed hospital that opened in April 2008 and has a lease that expires in 2028. This hospital was part of a three property acquisition announced in December 2010 and is currently being operated by Kindred Healthcare Inc. (formerly RehabCare). The purchase price of this hospital was $19.5 million, which included the assumption of a $16 million existing mortgage loan that matures in January 2018.

On July 18, 2011, we acquired the real estate of the 40-bed Vibra Specialty Hospital of DeSoto in Desoto, Texas for $13.0 million. Vibra Specialty Hospital of DeSoto is a new long-term acute care hospital that is currently ramping up its operations. This facility will be leased to a subsidiary of Vibra for a fixed term of 15 years with options to extend. In addition, we have made a $2.5 million equity investment in the operator of this facility for a 25% equity ownership.

On September 30, 2011, we purchased the real estate of a 40-bed long-term acute care facility in New Braunfels, Texas for $10.0 million. This facility will be leased to an affiliate of Post Acute Medical, LLC for a fixed term of 15 years with options to extend. In addition, we have made a $1.4 million equity investment for a 25% equity ownership in the operator of this facility and funded a $2.0 million working capital loan.

On June 17, 2010, we acquired three inpatient rehabilitation hospitals in Texas for an aggregate purchase price of $74 million. The properties acquired had existing leases in place, which we assumed, that have initial terms expiring in 2033. Each lease may, subject to conditions, be renewed by the operator for two additional ten-year terms.

As part of these acquisitions, we purchased the following assets: (dollar amounts in thousands)


	2011		2010
Land	$	17,218	$	6,264
Building		178,535		61,893
Intangible lease assets — subject to amortization (weighted average useful life of 13.5 years in 2011 and 23.1 years in 2010)		15,351		5,694

Total	$	211,104	$	73,851

The purchase price allocations attributable to the identifiable assets acquired and liabilities assumed related to the acquisitions made in 2011 are final except for the New Braunfels property. When all relevant information is obtained, resulting changes, if any, to our provisional purchase price allocation will be retrospectively adjusted to reflect new information obtained about the facts and circumstances that existed as of the respective acquisition date that, if known, would have affected the measurement of the amounts recognized.

From the respective acquisition dates, the seven hospitals acquired in 2011 contributed $5.5 million and $14.0 million of revenue and $3.7 million and $9.1 million of income (excluding related acquisition expenses) for the three and nine months ended September 30, 2011, respectively. In addition, we incurred $0.5 million and $3.2 million of acquisition related costs on consummated and non-consummated deals for the three and nine months ended September 30, 2011.

From the respective acquisition dates, the three hospitals acquired in 2010 contributed $1.9 million and $2.2 million of revenue and $1.4 million and $1.7 million of income (excluding related acquisition expenses) for the three and nine months ended September 30, 2010, respectively. In addition, we incurred $0.4 million and $1.3 million of acquisition related costs during the three and nine months ended September 30, 2010.

The results of operations for each of the properties acquired are included in our consolidated results from the effective date of each acquisition. The following table sets forth certain unaudited pro forma consolidated financial data for 2011 and 2010, as if each acquisition in 2011 and 2010 was consummated on the same terms at the beginning of 2010. Supplemental pro forma earnings were adjusted to exclude acquisition-related costs on consummated deals incurred in the three and nine months ended September 30, 2011 and 2010 (dollar amounts in thousands except per share/unit data).


	For the Three Months Ended September 30,				For the Nine Months Ended September 30,
	2011		2010		2011		2010
Total revenues	$	38,115	$	34,986	$	113,467	$	109,522
Net income		446		11,551		17,161		12,710
Net income per share/unit – diluted	$	—	$	0.10	$	0.15	$	0.12

Disposals

In April 2010, we sold the real estate of our Centinela Hospital, a 369-bed acute care medical center located in Inglewood, California, to Prime, for $75 million resulting in a gain of approximately $6 million. Due to this sale, operating results of our Inglewood facility have been included in discontinued operations for all prior periods.

Leasing Operations

As noted in our second quarter filing, the operator of our Denham Springs facility in Louisiana has not made all the payments required by the real estate lease agreement, and thus, the tenant is in default. During the second quarter of 2011, we evaluated alternative strategies for the recovery of our advances and accruals and at that time determined that the future cash flows of the current tenant and/or related collateral would, more likely than not, result in less than a full recovery of our receivables. As a result, we fully reserved for all outstanding receivables (including $1.5 million in billed rent, $0.2 million of unbilled rent, and $0.1 million of other receivables) with the exception of the $0.7 million promissory note that we expect is recoverable from existing collateral. In addition, we recorded a $0.6 million impairment charge against the real estate during the second quarter of 2011. We have not recorded any rental revenue or reversed previously established reserves during the third quarter, except for $0.2 million, which represents payments received from the tenant subsequent to the second quarter. At September 30, 2011, we continue to believe, based on existing collateral and the current real estate market, that the $0.7 million loan and the $4.4 million of real estate are fully recoverable; however, no assurances can be made that future reserves will not be needed.

As of September 30, 2011, we have advanced $28.8 million to the operator/lessee of Monroe Hospital in Bloomington, Indiana pursuant to a working capital loan agreement, including $0.6 million advanced in the 2011 third quarter related to a project at Monroe designed to increase revenue at the facility. In addition, as of September 30, 2011, we have $14.6 million of rent, interest and other charges owed to us by the operator, of which $5.5 million of interest receivables are significantly more than 90 days past due. Because the operator has not made all payments required by the working capital loan agreement and the related real estate lease agreement, we consider the loan to be impaired. During the first quarter of 2010, we evaluated alternative strategies for the recovery of our advances and accruals and at that time determined that the future cash flows of the current tenant or related collateral would, more likely than not, result in less than a full recovery of our loan advances. Accordingly, we recorded a $12 million charge in the 2010 first quarter to recognize the estimated impairment of the working capital loan. During the third quarter of 2010, we determined that it was reasonably likely that the existing tenant would be unable to make certain lease payments that become due in future years. Accordingly, we recorded a valuation allowance for unbilled straight-line rent in the amount of $2.5 million. At September 30, 2011, our net investment (exclusive of the related real estate) of $31.4 million is our maximum exposure to Monroe and the amount is deemed collectible/recoverable. In making this determination, we considered our first priority secured interest in approximately (i) $7 million in hospital patient receivables, (ii) cash balances of approximately $4 million, (iii) 100% of the membership interests of the operator/lessee and our assessment of the realizable value of our other collateral and (iv) continued improvement in operational revenue statistics compared to previous years.

We continue to evaluate possible strategies for the Monroe hospital. We have entered into a forbearance agreement with the operator whereby we have generally agreed, under certain conditions, not to fully exercise our rights and remedies under the lease and loan agreements during limited periods. We have not committed to the adoption of a plan to transition ownership or management of the Monroe hospital to any new operator, and there is no assurance that any such plan will be completed. Moreover, there is no assurance that any plan that we ultimately pursue will not result in additional charges for further impairment of our working capital loan. We have not recognized any interest income on the Monroe loan since it was considered impaired in the 2010 first quarter.

In September 2010, we exchanged properties with one of our tenants. In exchange for our acute care facility in Cleveland, Texas, we received a similar acute care facility in Hillsboro, Texas. The lease that was in place on our Cleveland facility was carried over to the new facility with no change in lease term or lease rate. This exchange was accounted for at fair value, resulting in a gain of $1.3 million (net of $0.2 million from the write-off of straight-line rent receivables).

In March 2010, we re-leased our Covington facility, located in Covington, Louisiana. The lease has a fixed term of 15 years with an option, at the lessee's discretion, to extend the term for three additional periods of five years each. Under the terms of the lease, rent during 2010 was based on an annual rate of $1.4 million, and on January 1, 2011, rent began increasing annually by 2%. At the end of each term, the tenant has the right to purchase the facility at a price generally equivalent to the greater of our undepreciated cost and fair market value. Separately, we also obtained an interest in the operations of the tenant whereby we may receive additional consideration based on the profitability of such operations.

In the 2010 second quarter, Prime paid us $12 million in additional rent related to our Shasta property, and we terminated our agreements with Prime concerning the additional rent, which could have paid us up to $20 million over the 10 year lease life. Of this $12 million in additional rent, $3.5 million has been recognized in income from lease inception through September 30, 2011, and we expect to recognize the other $8.5 million into income over the remainder of the lease life.

Loans

In April 2010, Prime repaid $40 million in other loans plus accrued interest.

Concentrations of Credit Risk

For the three months ended September 30, 2011 and 2010, revenue from affiliates of Prime (including rent and interest from loans) accounted for 30.9% and 33.8%, respectively, of total revenue. For the three months ended September 30, 2011 and 2010, revenue from Vibra (including rent and interest from working capital loans) accounted for 12.4% and 15.4%, respectively, of total revenue.

For the nine months ended September 30, 2011 and 2010, revenue from affiliates of Prime (including rent and interest from loans) accounted for 31.1% and 33.4%, respectively, of total revenue. For the nine months ended September 30, 2011 and 2010, revenue from Vibra (including rent and interest from working capital loans) accounted for 12.6% and 14.7%, respectively, of total revenue.

Debt

9 Months Ended

Sep. 30, 2011

Debt [Abstract]

Debt

4. Debt

The following is a summary of debt, net of discounts (dollar amounts in thousands):


	As of September 30, 2011				As of December 31, 2010
	Balance			Interest Rate	Balance			Interest Rate
Revolving credit facilities	$	39,600		Variable	$	—		Variable
2006 senior unsecured notes		125,000		Various		125,000		7.333% — 7.871%
2011 senior unsecured notes		450,000		6.875%		—
Exchangeable senior notes:
Principal amount		20,175		6.125% — 9.250%		91,175		6.125% — 9.250%
Unamortized discount		(248	)			(2,585	)

		19,927				88,590

Term loans:
Principal amount		14,486		6.200%		157,683		Various
Unamortized discount		—				(1,303	)

		14,486				156,380

	$	649,013			$	369,970

As of September 30, 2011, principal payments due for our debt (which exclude the effects of any discounts recorded) are as follows:


2011	$	9,232
2012		39,832
2013		11,249
2014		265
2015		283
Thereafter		588,400

Total	$	649,261

To fund the acquisitions disclosed in Note 3, we used cash on-hand, borrowed on our revolving credit facilities, used a portion of the proceeds from the sale of the 2011 senior unsecured notes, and assumed a $16 million mortgage loan. This mortgage loan requires monthly principal and interest payments based on a 30-year amortization period. The mortgage loan has a fixed rate at 6.2%, matures on January 1, 2018 and can be prepaid after January 1, 2013, subject to a certain prepayment premium.

In April 2011, our Operating Partnership and a wholly-owned subsidiary of our Operating Partnership closed on a private offering of $450 million unsecured senior notes. These notes mature in 2021 and the interest rate is fixed at 6.875% per year. Contemporaneously with the closing of the notes, we repaid and terminated our $150 million term loan facility (which was part of the credit facility entered into in 2010) and our $9 million collateralized term loan facility. In connection with the notes offering, we amended our existing credit agreement, which now provides for a $330 million unsecured revolving credit facility that matures in October 2015. As part of this amendment, we also lowered our interest rate to (1) the higher of the "prime rate" or federal funds rate plus 0.5%, plus a spread initially set at 1.60%, but that is adjustable from 1.60% to 2.40% based on current total leverage, or (2) LIBOR plus a spread initially set at 2.60%, but that is adjustable from 2.60% to 3.40% based on current total leverage. We paid down in full this revolving credit facility's outstanding balance with the proceeds from the notes offering.

In the 2011 third quarter, we used proceeds from our 2011 senior unsecured notes offering to repurchase 86.6% of the outstanding 9.25% exchangeable senior notes due 2013 at a weighted average price of 118.4% of the principal amount (or $84.1 million) plus accrued and unpaid interest pursuant to a cash tender offer. The interest savings from the retirement of this debt will offset the majority of the premium paid to retire it, and the potential dilution effect from the convertible aspect of these notes is removed.

In connection with these 2011 refinancing activities, we recognized charges of $10.4 million and $14.2 million for the three and nine months ended September 30, 2011, respectively, related to the write-off of previously deferred loan costs and discounts associated with the payoff of the debt instruments noted above.

In April 2010, we completed a public offering of common stock (the "Offering") resulting in net proceeds, after underwriting discount and commissions, of approximately $279 million. See Note 5 to our condensed consolidated financial statements for further information. We used the net proceeds from the Offering to repurchase 93% of the outstanding 6.125% exchangeable senior notes due 2011 at a price of 103% of the principal amount plus accrued and unpaid interest (or $136.3 million) pursuant to a cash tender offer. In addition, we paid off a $30 million term loan. Finally, in May 2010, we closed on a $450 million credit facility, and the proceeds of such along with the Offering were used to repay in full all outstanding obligations under the previous credit facility. These refinancing activities resulted in a charge of $0.3 million and $6.6 million for the three and nine months ended September 30, 2010, respectively.

At September 30, 2011, $65 million of our 2006 senior unsecured notes carried a variable rate of 2.67%, while the remaining $60 million was fixed at rates ranging from 7.333% to 7.715%. During the second quarter 2010, we entered into an interest rate swap to fix $65 million of our $125 million senior unsecured notes, which started July 31, 2011 (date on which the interest rate turned variable) and will run through maturity date (or July 2016), at a rate of 5.507%. We also entered into an interest rate swap to fix $60 million of our senior notes starting October 31, 2011 (date on which the related interest rate is scheduled to turn variable) through the maturity date (or October 2016) at a rate of 5.675%. At September 30, 2011, the fair value of the interest rate swaps is $12.0 million, which is reflected in accounts payable and accrued expenses on the condensed consolidated balance sheet.

We account for our interest rate swaps as cash flow hedges. Accordingly, the effective portion of changes in the fair value of our swaps is recorded as a component of accumulated other comprehensive income/loss on the balance sheet until the underlying debt matures while the ineffective portion is recorded through earnings. We estimate the fair value of interest rate swaps using the market standard methodology of netting the discounted fixed cash payments and the discounted expected variable cash receipts. The variable cash receipts are based on an expectation of interest rates derived from observable market interest rate curves. In addition, credit valuation adjustments are incorporated in the fair values to account for potential nonperformance risk, both our own nonperformance risk and the respective counterparty's nonperformance risk. We did not have any hedge ineffectiveness in the periods; therefore, there was no income statement effect recorded during the three and nine month periods ended September 30, 2011 or 2010.

Our debt facilities impose certain restrictions on us, including restrictions on our ability to: incur debts; grant liens; provide guarantees in respect of obligations of any other entity; make redemptions and repurchases of our capital stock; prepay, redeem or repurchase debt; engage in mergers or consolidations; enter into affiliated transactions; dispose of real estate; and change our business. In addition, the agreements governing our debt facilities limit the amount of dividends we can pay to 95% of normalized adjusted funds from operations, as defined in the agreements, on a rolling four quarter basis starting for the fiscal quarter ending March 31, 2012 and thereafter. Prior to March 31, 2012, a similar dividend restriction exists but at a higher percentage for transitional purposes. These agreements also contain provisions for the mandatory prepayment of outstanding borrowings under these facilities from the proceeds received from the sale of properties, except a portion may be reinvested subject to certain limitations, as defined in the credit facility agreement.

In addition to these restrictions, the amended credit facility contains customary financial and operating covenants, including covenants relating to our total leverage ratio, fixed charge coverage ratio, mortgage secured leverage ratio, recourse mortgage secured leverage ratio, consolidated adjusted net worth, facility leverage ratio, and borrowing base interest coverage ratio. This facility also contains customary events of default, including among others, nonpayment of principal or interest, material inaccuracy of representations and failure to comply with our covenants. If an event of default occurs and is continuing under the facility, the entire outstanding balance may become immediately due and payable. At September 30, 2011, we were in compliance with all such financial and operating covenants.

Common Stock

9 Months Ended

Sep. 30, 2011

Common Stock [Abstract]

Common Stock

5. Common Stock

In April 2010, we completed a public offering of 26 million shares of common stock at $9.75 per share. Including the underwriters' purchase of 3.9 million additional shares to cover over allotments, net proceeds from the Offering, after underwriting discount and commissions, approximated $279 million. We used the net proceeds from the Offering to fund the tender offer as discussed in Note 4 with any remaining proceeds to be used for general corporate purposes including funding the acquisition in June 2010.

During the first quarter of 2010, we sold 0.9 million shares of our common stock under our at-the-market equity offering program, at an average price of $10.77 per share, for total proceeds, net of a 2% sales commission, of $9.5 million.

- Definition

The entire disclosure for shareholders' equity, comprised of portions attributable to the parent entity and noncontrolling interest, if any, including other comprehensive income (as applicable). Including, but not limited to: (1) balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings; (2) accumulated balance for each classification of other comprehensive income and total amount of comprehensive income; (3) amount and nature of changes in separate accounts, including the number of shares authorized and outstanding, number of shares issued upon exercise and conversion, and for other comprehensive income, the adjustments for reclassifications to net income; (4) rights and privileges of each class of stock authorized; (5) basis of treasury stock, if other than cost, and amounts paid and accounting treatment for treasury stock purchased significantly in excess of market; (6) dividends paid or payable per share and in the aggregate for each class of stock for each period presented; (7) dividend restrictions and accumulated preferred dividends in arrears (in aggregate and per share amount); (8) retained earnings appropriations or restrictions, such as dividend restrictions; (9) impact of change in accounting principle, initial adoption of new accounting principle and correction of an error in previously issued financial statements; (10) shares held in trust for Employee Stock Ownership Plan (ESOP); (11) deferred compensation related to issuance of capital stock; (12) note received for issuance of stock; (13) unamortized discount on shares; (14) description, terms, and number of warrants or rights outstanding; (15) shares under subscription and subscription receivables, effective date of new retained earnings after quasi-reorganization and deficit eliminated by quasi-reorganization and, for a period of at least ten years after the effective date, the point in time from which the new retained dates; and (16) retroactive effective of subsequent change in capital structure.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 12
-Paragraph 10
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Article 3

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 4
-Section 08
-Paragraph d

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 43
-Chapter 1
-Section B
-Paragraph 7, 11A
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 129
-Paragraph 2, 3, 4, 5, 6, 7, 8
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 5
-Paragraph 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph 29, 30, 31
-Article 5

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section E

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 4
-Section C

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(d),(e))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 20: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 4.E)
-URI http://asc.fasb.org/extlink&oid=6228006&loc=d3e74512-122707

Reference 21: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Preferred Stock
-URI http://asc.fasb.org/extlink&oid=6521494

Reference 22: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.29-31)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 23: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 4
-Subparagraph (SAB TOPIC 4.C)
-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187143-122770

+ Details

Stock Awards

9 Months Ended

Sep. 30, 2011

Stock Awards [Abstract]

Stock Awards

6. Stock Awards

Our Second Amended and Restated Medical Properties Trust, Inc. 2004 Equity Incentive Plan (the "Equity Incentive Plan") authorizes the issuance of common stock options, restricted stock, restricted stock units, deferred stock units, stock appreciation rights, performance units and awards of interests in our Operating Partnership. The Equity Incentive Plan is administered by the Compensation Committee of the Board of Directors. We have reserved 7,441,180 shares of common stock for awards under the Equity Incentive Plan for which 2,642,597 shares remain available for future stock awards as of September 30, 2011. We awarded the following during 2011 and 2010:

Time-based awards - We granted 269,085 and 277,680 shares in 2011 and 2010, respectively, of time-based restricted stock to management, independent directors, and certain employees. These awards vest quarterly based on service, over three years, in equal amounts.

Performance-based awards - Our management team and certain employees (2011 only) were awarded 229,938 and 182,600 performance based awards in 2011 and 2010, respectively. These awards vest ratably over a three year period based on the achievement of certain total shareholder return measures, with a carry-back and carryforward provision through December 31, 2014 (for the 2010 awards) and December 31, 2015 (for the 2011 awards). Dividends on these awards are paid only upon achievement of the performance measures.

Multi-year Performance-based awards - We awarded 600,000 shares in 2011 of multi-year performance-based awards to management and certain employees. These shares are subject to three-year cumulative performance hurdles based on total shareholder return. At the end of the three-year performance period, any earned shares will be subject to an additional two years of ratable time-based vesting on an annual basis. Dividends are paid on these shares only upon achievement of the performance measures.

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 123R
-Paragraph 64, 65, A240
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Statement of Position (SOP)
-Number 93-6
-Paragraph 53
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 14

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 40
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

+ Details

Partner's Capital

9 Months Ended

Sep. 30, 2011

Partners' Capital [Abstract]

Partner's Capital

7. Partner's Capital

The Operating Partnership is made up of a general partner, Medical Properties Trust, LLC ("General Partner") and limited partners including the Company (which owns 100% of the General Partner) and three other partners who are employees. By virtue of its ownership of the General Partner, the Company has a 99.9% ownership interest in Operating Partnership via its ownership of all the common units. The remaining ownership interest is held by the three employees via their ownership of LTIP units. These LTIP units were issued to the employees pursuant to the 2007 Multi-Year Incentive Plan, which is part of the Equity Incentive Plan and once vested in accordance with their award agreement, may be converted to common units per the Second Amended and Restated Agreement of Limited Partnership of MPT Operating Partnership, L.P. ("Operating Partnership Agreement")

In regards to distributions, the Operating Partnership shall distribute cash at such times and in such amounts as are determined by the General Partner in its sole and absolute discretion, to common unit holders who are common unit holders on the record date. However, per the Operating Partnership Agreement, the General Partner shall use its reasonable efforts to cause the Operating Partnership to distribute amounts sufficient to enable the Company to pay stockholder dividends that will allow the Company to (i) meet its distribution requirement for qualification as a REIT and (ii) avoid any federal income or excise tax liability imposed by the Internal Revenue Code, other than to the extent the Company elects to retain and pay income tax on its net capital gain. In accordance with the Operating Partnership Agreement, LTIP units are treated as common units for distribution purposes.

The Operating Partnership's net income will generally be allocated first to the General Partner to the extent of any cumulative losses and then to the limited partners in accordance with their respective percentage interests in the common units issued by the Operating Partnership. Any losses of the Operating Partnership will generally be allocated first to the limited partners until their capital account is zero and then to the General Partner. In accordance with the Operating Partnership Agreement, LTIP units are treated as common units for purposes of income and loss allocations.

Limited partners have the right to require the Operating Partnership to redeem part or all of their common units. It is at the Operating Partnership's discretion to redeem such common units for cash based on the fair market value of an equivalent number of shares of the Company's common stock at the time of redemption, or alternatively, redeem the common units for shares of the Company's common stock on a one-for-one basis, subject to adjustment in the event of stock splits, stock dividends, or similar events. In order for LTIP units to be redeemed, they must first be converted to common units and then must wait two years from the issuance of the LTIP units to be redeemed.

- Definition

The entire disclosure for the formation, structure, control and ownership of the partnership. Disclosures related to accounts comprising partners' capital. Includes balances of general partners' capital account, limited partners' capital account, preferred partners' capital account and total partners' capital account and units outstanding; accumulated other comprehensive income; amount and nature of changes to amount of partner's capital and units outstanding by class, rights and privileges for each class of units; distribution policies and distributions paid by unit class; impact of and correction of an error in previously issued financial statements; limitations of partners' liability; redemption, conversion and distribution policies; and deferred compensation related to the issuance of units.

+ References + Details

Fair Value Of Financial Instruments

9 Months Ended

Sep. 30, 2011

Fair Value Of Financial Instruments [Abstract]

Fair Value Of Financial Instruments

8. Fair Value of Financial Instruments

We have various assets and liabilities that are considered financial instruments. We estimate that the carrying value of cash and cash equivalents, and accounts payable and accrued expenses approximate their fair values. Included in our accounts payable and accrued expenses are our interest rate swaps, which are recorded at fair value based on Level 2 observable market assumptions using standardized derivative pricing models. We estimate the fair value of our loans, interest, and other receivables by discounting the estimated future cash flows using the current rates at which similar receivables would be made to others with similar credit ratings and for the same remaining maturities. We determine the fair value of our exchangeable notes based on quotes from securities dealers and market makers. We estimate the fair value of our senior notes, revolving credit facilities, and term loans based on the present value of future payments, discounted at a rate which we consider appropriate for such debt.

The following table summarizes fair value information for our financial instruments (dollar amounts in thousands):


	September 30, 2011						December 31, 2010
Asset (Liability)	Book Value			Fair Value			Book Value			Fair Value
Interest and rent receivables	$	28,822		$	22,418		$	26,176		$	20,265
Loans		221,131			223,556			215,985			209,126
Debt, net		(649,013	)		(597,802	)		(369,970	)		(359,910	)

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 133
-Paragraph 44A, 44B
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15C, 15D
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15A
-Subparagraph a-d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15B
-Subparagraph a, b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 3, 10, 14, 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 157
-Paragraph 32, 33, 34
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 159
-Paragraph 17-22, 27, 28
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6925170&loc=d3e19207-110258

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13537-108611

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13433-108611

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13504-108611

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6925170&loc=d3e19296-110258

+ Details

Discontinued Operations

9 Months Ended

Sep. 30, 2011

Discontinued Operations [Abstract]

Discontinued Operations

9. Discontinued Operations

In December 2010, we sold the real estate of our Montclair Hospital, an acute care medical center, to Prime for proceeds of $20.0 million. We realized a gain on the sale of $2.2 million.

In October 2010, we sold the real estate of our Sharpstown hospital in Houston, Texas to a third party for proceeds of $3.0 million resulting in a gain of $0.7 million.

In April 2010, we sold the real estate of our Centinela Hospital, a 369-bed acute care medical center located in Inglewood, California, to Prime for $75 million resulting in a gain of approximately $6 million.

The following table presents the results of discontinued operations, which include the revenue and expenses of the three previously-owned facilities noted above, for the three and nine months ended September 30, 2011 and 2010 (dollar amounts in thousands except per share/unit amounts):


	For the Three Months Ended September 30,					For the Nine Months Ended September 30,
	2011			2010		2011		2010
Revenues	$	—		$	572	$	—	$	4,264
Gain on sale		—			—		5		6,178
Income (loss)		(6	)		301		141		7,463
Earnings per share/unit — diluted	$	—		$	—	$	—	$	0.08

- Definition

The entire disclosure for the facts and circumstances leading to the completed or expected disposal, manner and timing of disposal, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the segment in which the disposal group was reported, and the classification (whether sold or classified as held for sale) and carrying value of the assets and liabilities comprising the disposal group. Includes all disposal groups, including those classified as components of the entity (discontinued operations).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 144
-Paragraph 43-48
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2941-110230

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1510-107760

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1020-107759

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e1012-107759

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1474-107760

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 360
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6390789&loc=d3e2443-110228

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1436-107760

+ Details

Earnings Per Share

9 Months Ended

Sep. 30, 2011

Earnings Per Share [Abstract]

Earnings Per Share

10. Earnings Per Share/Common Unit

Medical Properties Trust, Inc.

Our earnings per share were calculated based on the following (amounts in thousands):

		$(000,000)			$(000,000)
	For the Three Months Ended September 30,
	2011			2010
Numerator:
Income (loss) from continuing operations	$	474		$	8,663
Non-controlling interests' share in continuing operations		(43	)		(45	)
Participating securities' share in earnings		(264	)		(316	)

Income (loss) from continuing operations, less participating securities' share in earnings		167			8,302
Income (loss) from discontinued operations attributable to MPT common stockholders		(6	)		301

Net income, less participating securities' share in earnings	$	161		$	8,603

Denominator
Basic weighted-average common shares		110,714			110,046
Dilutive share options		5			—

Dilutive weighted-average common shares		110,719			110,046

		$(000,000)			$(000,000)
	For the Nine Months Ended September 30,
	2011			2010
Numerator:
Income (loss) from continuing operations	$	13,834		$	4,920
Non-controlling interests' share in continuing operations		(131	)		(63	)
Participating securities' share in earnings		(860	)		(994	)

Income (loss) from continuing operations, less participating securities' share in earnings		12,843			3,863
Income (loss) from discontinued operations attributable to MPT common stockholders		141			7,463

Net income, less participating securities' share in earnings	$	12,984		$	11,326


Denominator
Basic weighted-average common shares		110,568			97,573
Dilutive share options		8			2

Dilutive weighted-average common shares		110,576			97,575

MPT Operating Partnership, L.P.

Our earnings per common unit were calculated based on the following (amounts in thousands):

		$(000,000)			$(000,000)
	For the Three Months Ended September 30,
	2011			2010
Numerator:
Income (loss) from continuing operations	$	492		$	8,654
Non-controlling interests' share in continuing operations		(43	)		(45	)
Participating securities' share in earnings		(264	)		(316	)

Income (loss) from continuing operations, less participating securities' share in earnings		185			8,293
Income (loss) from discontinued operations attributable to MPT Operating Partnership partners		(6	)		301

Net income, less participating securities' share in earnings	$	179		$	8,594


Denominator
Basic weighted-average units		110,714			110,046
Dilutive options		5			—

Dilutive weighted-average units		110,719			110,046

		$(000,000)			$(000,000)
	For the Nine Months Ended September 30,
	2011			2010
Numerator:
Income (loss) from continuing operations	$	13,896		$	4,994
Non-controlling interests' share in continuing operations		(131	)		(63	)
Participating securities' share in earnings		(860	)		(994	)

Income (loss) from continuing operations, less participating securities' share in earnings		12,905			3,937
Income (loss) from discontinued operations attributable to MPT Operating Partnership partners		141			7,463

Net income, less participating securities' share in earnings	$	13,046		$	11,400


Denominator
Basic weighted-average units		110,568			97,573
Dilutive options		8			2

Dilutive weighted-average units		110,576			97,575

For the three and nine months ended September 30, 2011 and 2010, 0.1 million of options were excluded from the diluted earnings per share/unit calculation as they were not determined to be dilutive. Shares/units that may be issued in the future in accordance with our exchangeable senior notes were excluded from the diluted earnings per share/unit calculation as they were not determined to be dilutive.

Contingencies

9 Months Ended

Sep. 30, 2011

Contingencies [Abstract]

Contingencies

11. Contingencies

We are a party to various legal proceedings incidental to our business. In the opinion of management, after consultation with legal counsel, the ultimate liability, if any, with respect to those proceedings is not presently expected to materially affect our financial position, results of operations or cash flows.

- Definition

The entire disclosure for commitments and contingencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 14
-Paragraph 3
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 5
-Paragraph 9, 10, 11, 12
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.25)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 450
-SubTopic 20
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14435-108349

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 460
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 440
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

+ Details

Comprehensive Income (Loss)

9 Months Ended

Sep. 30, 2011

Comprehensive Income (Loss) [Abstract]

Comprehensive Income (Loss)

12. Comprehensive Income (Loss)

Medical Properties Trust, Inc.

The following table provides a summary of comprehensive income (loss) for the applicable periods (in thousands):

		$(000,000)			$(000,000)
	For the Three Months Ended September 30,
	2011			2010
Net income	$	468		$	8,964
Other comprehensive income (loss):
Unrealized loss on interest rate swap		(5,272	)		(3,845	)

Total comprehensive income (loss)		(4,804	)		5,119
Comprehensive income attributable to non-controlling interests		(43	)		(45	)

Comprehensive income (loss) attributable to MPT common stockholders	$	(4,847	)	$	5,074

		$(000,000)			$(000,000)
	For the Nine Months Ended September 30,
	2011			2010
Net income	$	13,975		$	12,383
Other comprehensive income (loss):
Unrealized loss on interest rate swap		(8,341	)		(7,005	)

Total comprehensive income (loss)		5,634			5,378
Comprehensive income attributable to non-controlling interests		(131	)		(63	)

Comprehensive income (loss) attributable to MPT common stockholders	$	5,503		$	5,315

MPT Operating Partnership, L.P.

The following table provides a summary of comprehensive income (loss) for the applicable periods (in thousands):

		$(000,000)			$(000,000)
	For the Three Months Ended September 30,
	2011			2010
Net income	$	486		$	8,955
Other comprehensive income (loss):
Unrealized loss on interest rate swap		(5,272	)		(3,845	)

Total comprehensive income (loss)		(4,786	)		5,110
Comprehensive income attributable to non-controlling interests		(43	)		(45	)

Comprehensive income (loss) attributable to MPT Operating Partnership partners	$	(4,829	)	$	5,065

		$(000,000)			$(000,000)
	For the Nine Months Ended September 30,
	2011			2010
Net income	$	14,037		$	12,457
Other comprehensive income (loss):
Unrealized loss on interest rate swap		(8,341	)		(7,005	)

Total comprehensive income (loss)		5,696			5,452
Comprehensive income attributable to non-controlling interests		(131	)		(63	)

Comprehensive income (loss) attributable to MPT Operating Partnership partners	$	5,565		$	5,389

- Definition

The entire disclosure for comprehensive income. Includes, but is not limited to, the following: 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income. Components of comprehensive income include: (1) foreign currency translation adjustments; (2) gains (losses) on foreign currency transactions that are designated as, and are effective as, economic hedges of a net investment in a foreign entity; (3) gains (losses) on intercompany foreign currency transactions that are of a long-term-investment nature, when the entities to the transaction are consolidated, combined, or accounted for by the equity method in the reporting enterprise's financial statements; (4) change in the market value of a futures contract that qualifies as a hedge of an asset reported at fair value; (5) unrealized holding gains (losses) on available-for-sale securities and that resulting from transfers of debt securities from the held-to-maturity category to the available-for-sale category; (6) a net loss recognized as an additional pension liability not yet recognized as net periodic pension cost; and (7) the net gain (loss) and net prior service cost or credit for pension plans and other postretirement benefit plans.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 130
-Paragraph 14-26
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e637-108580

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 14
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e681-108580

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e653-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=6959260&loc=d3e187085-122770

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 16
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e709-108580

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 55
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6920433&loc=d3e998-108581

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e640-108580

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Reclassification Adjustments
-URI http://asc.fasb.org/extlink&oid=6522872

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 17
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e716-108580

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e689-108580

+ Details

Subsequent Events

9 Months Ended

Sep. 30, 2011

Subsequent Events [Abstract]

Subsequent Events

13. Subsequent Events

In October 2011, we entered into agreements with Emerus Holdings to acquire, provide development funding for, and lease three acute care hospitals near San Antonio, Texas. We expect our investment in these three facilities, once built, will approximate $30 million. These three facilities will be leased under a master lease with an initial term of 15 years and three five-year extension options.

On November 4, 2011, we acquired Hoboken University Medical Center in Hoboken, New Jersey, a 350-bed acute care facility. The total investment for this transaction is $75.0 million, which includes 100% ownership of the real estate, a secured working capital loan of up to $20 million, and a $5 million convertible note. The lease with the tenant has an initial term of 15 years with six five-year extension options.

Income Taxes

9 Months Ended

Sep. 30, 2011

Income Taxes [Abstract]

Income Taxes

14. Income Taxes

With the early prepayment of working capital loans by Prime and the impairment of the Monroe loan in 2010 as more fully described in Note 3, we did not believe that one of our taxable REIT subsidiaries would generate enough taxable income to use the federal and state net operating losses within the carry-forward period specified by law. Therefore, in the 2010 second quarter, we fully reserved for the $1.5 million deferred tax asset, of which $1.2 million relates to discontinued operations. We continue to monitor this valuation allowance and if circumstances change (such as new loans or other transactions), we will adjust this valuation allowance accordingly.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 08
-Paragraph h
-Article 4

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 136, 172
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 109
-Paragraph 43, 44, 45, 46, 47, 48, 49
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 15
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(h))
-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319

+ Details

Executive Severance	9 Months Ended
Executive Severance	Sep. 30, 2011
Executive Severance [Abstract]
Executive Severance	15. Executive Severance On June 11, 2010, we announced the resignation of our general counsel effective June 15, 2010. Pursuant to the terms of his separation agreement, we accelerated the vesting of certain previously awarded shares of restricted stock resulting in additional stock compensation expense of $0.9 million. In addition, we agreed to pay him a one time cash payment of $1.9 million on December 16, 2010. This total severance of $2.8 million is included in general and administrative expense for the nine month period ended September 30, 2010.

Condensed Consolidating Financial Information

9 Months Ended

Sep. 30, 2011

Condensed Consolidating Financial Information [Abstract]

Condensed Consolidating Financial Information

16. Condensed Consolidating Financial Information

The following tables present the condensed consolidating financial information for (a) Medical Properties Trust, Inc. ("Parent" and a guarantor to our 2011 senior unsecured notes), (b) MPT Operating Partnership, L.P. and MPT Finance Corporation ("Subsidiary Issuer"), (c) on a combined basis, the guarantors of our 2011 unsecured senior notes ("Subsidiary Guarantors"), and (d) on a combined basis, the non-guarantor subsidiaries ("Non-Guarantor Subsidiaries"). Separate financial statements of the Subsidiary Guarantors are not presented because the guarantee by each 100% owned Subsidiary Guarantor is joint and several, and we believe separate financial statements and other disclosures regarding the Subsidiary Guarantors are not material to investors. Furthermore, there are no significant legal restrictions on the Parent's ability to obtain funds from its subsidiaries by dividend or loan.

The guarantees by the Subsidiary Guarantors may be released and discharged upon: (1) any sale, exchange or transfer of all of the capital stock of a Subsidiary Guarantor; (2) the merger or consolidation of a Subsidiary Guarantor with a Subsidiary Issuer or any other Subsidiary Guarantor; (3) the proper designation of any Subsidiary Guarantor by the Subsidiary Issuers as "unrestricted" for covenant purposes under the indenture governing the 2011 senior unsecured notes; (4) the legal defeasance or covenant defeasance or satisfaction and discharge of the indenture; (5) a liquidation or dissolution of a Subsidiary Guarantor permitted under the indenture governing the 2011 senior unsecured notes; or (6) the release or discharge of the Subsidiary Guarantor from its guarantee obligations under our revolving credit facility.

Condensed Consolidated Balance Sheet

September 30, 2011

(in thousands)


	Parent		Subsidiary Issuers		Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Assets
Real estate assets
Land, buildings and improvements and intangible lease assets	$	—	$	86	$	1,087,256		$	170,946		$	—		$	1,258,288
Mortgage loans		—		—		165,000			—			—			165,000

Gross investment in real estate assets		—		86		1,252,256			170,946			—			1,423,288
Accumulated depreciation and amortization		—		—		(87,681	)		(13,091	)		—			(100,772	)

Net investment in real estate assets				86		1,164,575			157,855			—			1,322,516
Cash & cash equivalents		—		113,132		—			1,236			—			114,368
Interest and rent receivable		—		505		22,184			6,133			—			28,822
Straight-line rent receivable		—		—		25,158			9,445			—			34,603
Other loans		—		177		230			55,724			—			56,131
Net intercompany receivable (payable)		21,923		869,106		(856,530	)		(34,499	)		—			—
Investment in subsidiaries		838,099		462,310		43,020			—			(1,343,429	)		—
Other assets		—		21,794		1,199			16,256			—			39,249

Total Assets	$	860,022	$	1,467,110	$	399,836		$	212,150		$	(1,343,429	)	$	1,595,689


Liabilities and Equity
Liabilities
Debt, net	$	—	$	594,927	$	—		$	54,086		$	—		$	649,013
Accounts payable and accrued expenses		22,358		33,481		1,416			411			—			57,666
Deferred revenue		—		603		18,277			4,696			—			23,576
Lease deposits and other obligations to tenants		—		—		26,641			1,129			—			27,770

Total liabilities		22,358		629,011		46,334			60,322			—			758,025
Total Medical Properties Trust Inc. stockholder's equity		837,564		837,999		353,502			151,828			(1,343,329	)		837,564

Non-controlling interests		100		100		—			—			(100	)		100

Total equity		837,664		838,099		353,502			151,828			(1,343,429	)		837,664

Total Liabilities and Equity	$	860,022	$	1,467,110	$	399,836		$	212,150		$	(1,343,429	)	$	1,595,689

Condensed Consolidated Statements of Income

For the Three Months Ended September 30, 2011

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	26,608	$	4,461		$	(331	)	$	30,738
Straight-line rent		—			—			1,255		547			—			1,802
Interest and fee income		—			1,351			4,000		1,088			(1,188	)		5,251

Total revenues		—			1,351			31,863		6,096			(1,519	)		37,791
Expenses
Real estate depreciation and amortization		—			—			7,455		975			—			8,430
Impairment charge		—			—			—		—			—			—
Property-related		—			87			211		345			(331	)		312
General and administrative		18			6,348			—		(630	)		—			5,736
Acquisition expenses		—			513			17		—			—			530

Total operating expenses		18			6,948			7,683		690			(331	)		15,008

Operating income (expense)		(18	)		(5,597	)		24,180		5,406			(1,188	)		22,783
Other income (expense)
Interest income and other		—			44			84		(77	)		—			51
Debt refinancing costs		—			(10,425	)		—		—			—			(10,425	)
Interest expense		—			(11,735	)		230		(1,618	)		1,188			(11,935	)

Net other income (expense)		—			(22,116	)		314		(1,695	)		1,188			(22,309	)

Income (loss) from continuing operations		(18	)		(27,713	)		24,494		3,711			—			474
Income (loss) from discontinued operations		—			—			—		(6	)		—			(6	)
Equity in earnings of consolidated subsidiaries net of income taxes		486			28,199			1,112		—			(29,797	)		—

Net income (loss)		468			486			25,606		3,705			(29,797	)		468
Net income (loss) attributable to non-controlling interests		(43	)		(43	)		—		—			43			(43	)

Net income (loss) attributable to MPT common stockholders	$	425		$	443		$	25,606	$	3,705		$	(29,754	)	$	425

Condensed Consolidated Statements of Income

For the Nine Months Ended September 30, 2011

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	76,907	$	12,606		$	(994	)	$	88,519
Straight-line rent		—			—			3,891		1,715			—			5,606
Interest and fee income		—			4,118			12,677		3,105			(4,088	)		15,812

Total revenues		—			4,118			93,475		17,426			(5,082	)		109,937
Expenses
Real estate depreciation and amortization		—			—			21,914		2,764			—			24,678
Impairment charge		—			—			564		—			—			564
Property-related		—			87			513		1,023			(994	)		629
General and administrative		62			18,356			—		2,010			—			20,428
Acquisition expenses		—			2,717			469		—			—			3,186

Total operating expenses		62			21,160			23,460		5,797			(994	)		49,485

Operating income (expense)		(62	)		(17,042	)		70,015		11,629			(4,088	)		60,452
Other income (expense)
Interest income and other		—			42			84		(68	)		—			58
Debt refinancing costs		—			(14,109	)		—		(105	)		—			(14,214	)
Interest expense		—			(31,750	)		488		(5,288	)		4,088			(32,462	)

Net other income (expense)		—			(45,817	)		572		(5,461	)		4,088			(46,618	)

Income (loss) from continuing operations		(62	)		(62,859	)		70,587		6,168			—			13,834
Income (loss) from discontinued operations		—			—			98		43			—			141
Equity in earnings of consolidated subsidiaries net of income taxes		14,037			76,896			3,457		—			(94,390	)		—

Net income (loss)		13,975			14,037			74,142		6,211			(94,390	)		13,975
Net income (loss) attributable to non-controlling interests		(131	)		(131	)		—		—			131			(131	)

Net income (loss) attributable to MPT common stockholders	$	13,844		$	13,906		$	74,142	$	6,211		$	(94,259	)	$	13,844

Condensed Consolidated Statements of Cash Flows

For the Nine Months Ended September 30, 2011

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	(124	)	$	(26,727	)	$	86,972		$	7,007		$	—		$	67,128

Investing Activities
Real estate acquired		—			—			(168,600	)		(27,911	)		—			(196,511	)
Principal received on loans receivable		—			—			—			2,898			—			2,898
Proceeds from sales of real estate		—			—			—			—			—			—
Investments in and advances to subsidiaries		67,126			(89,763	)		89,135			504			(67,002	)		—
Investments in loans receivable and other investments		—			(205	)		(3,314	)		(13,281	)		—			(16,800	)
Construction in progress and other		—			—			(12,297	)		—			—			(12,297	)

Net cash provided by (used in) investing activities		67,126			(89,968	)		(95,076	)		(37,790	)		(67,002	)		(222,710	)

Financing Activities
Revolving credit facilities, net		—			—			—			39,600			—			39,600
Additions to term debt		—			450,000			—			—			—			450,000
Payments of term debt		—			(229,271	)		—			(8,539	)		—			(237,810	)
Distributions paid		(67,002	)		(67,194	)		—			—			67,002			(67,194	)
Sale of common stock, net		—			—			—			—			—			—
Lease deposits and other obligations to tenants		—			—			8,104			(491	)		—			7,613
Debt issuance costs paid and other financing activities		—			(20,530	)		—			(137	)		—			(20,667	)

Net cash provided by financing activities		(67,002	)		133,005			8,104			30,433			67,002			171,542

Increase (decrease) in cash and cash equivalents for period		—			16,310			—			(350	)		—			15,960
Cash and cash equivalents at beginning of period		—			96,822			—			1,586			—			98,408

Cash and cash equivalents at end of period	$	—		$	113,132		$	—		$	1,236		$	—		$	114,368

Condensed Consolidated Balance Sheet

December 31, 2010

(in thousands)


	Parent		Subsidiary Issuers		Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated

Assets
Real estate assets
Land, buildings and improvements and intangible lease assets	$	—	$	297	$	903,630		$	128,442		$	—		$	1,032,369
Mortgage loans		—		—		165,000			—			—			165,000

Gross investment in real estate assets		—		297		1,068,630			128,442			—			1,197,369
Accumulated depreciation and amortization		—		—		(65,767	)		(10,327	)		—			(76,094	)

Net investment in real estate assets		—		297		1,002,863			118,115			—			1,121,275
Cash & cash equivalents		—		96,822		—			1,586			—			98,408
Interest and rent receivable		—		157		20,727			5,292			—			26,176
Straight-line rent receivable		—		—		21,180			7,732			—			28,912
Other loans		—		178		—			50,807			—			50,985
Net intercompany receivable (payable)		21,944		774,771		(767,395	)		(29,320	)		—			—
Investment in subsidiaries		899,949		390,232		42,970			—			(1,333,151	)		—
Other assets		—		10,289		1,215			11,554			—			23,058

Total Assets	$	921,893	$	1,272,746	$	321,560		$	165,766		$	(1,333,151	)	$	1,348,814


Liabilities and Equity
Liabilities
Debt, net	$	—	$	361,537	$	—		$	8,433		$	—		$	369,970
Accounts payable and accrued expenses		22,317		10,824		2,430			403			—			35,974
Deferred revenue		—		436		17,826			4,875			—			23,137
Lease deposits and other obligations to tenants		—		—		18,539			1,618			—			20,157

Total liabilities		22,317		372,797		38,795			15,329			—			449,238

Total Medical Properties Trust Inc. stockholder's equity		899,462		899,835		282,765			150,437			(1,333,037	)		899,462

Non-controlling interests		114		114		—			—			(114	)		114

Total equity		899,576		899,949		282,765			150,437			(1,333,151	)		899,576

Total Liabilities and Equity	$	921,893	$	1,272,746	$	321,560		$	165,766		$	(1,333,151	)	$	1,348,814

Condensed Consolidated Statements of Income

For the Three Months Ended September 30, 2010

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated

Revenues
Rent billed	$	—		$	—		$	20,116		$	3,682		$	(326	)	$	23,472
Straight-line rent		—			—			(1,612	)		488			—			(1,124	)
Interest and fee income		—			1,420			4,216			2,192			(1,532	)		6,296

Total revenues		—			1,420			22,720			6,362			(1,858	)		28,644
Expenses
Real estate depreciation and amortization		—			—			5,421			788			—			6,209
Impairment charge		—			—			—			—			—			—
Property-related		—			(43	)		640			329			(326	)		600
General and administrative		(9	)		5,781			—			77			—			5,849
Acquisition expenses		—			364			—			—			—			364

Total operating expenses		(9	)		6,102			6,061			1,194			(326	)		13,022

Operating income (loss)		9			(4,682	)		16,659			5,168			(1,532	)		15,622
Other income (expense)
Interest income and other		—			(17	)		1,494			(2	)		—			1,475
Debt refinancing costs		—			(342	)		—			—			—			(342	)
Interest expense		—			(8,058	)		(5	)		(1,561	)		1,532			(8,092	)

Net other income (expense)		—			(8,417	)		1,489			(1,563	)		1,532			(6,959	)

Income (loss) from continuing operations		9			(13,099	)		18,148			3,605			—			8,663
Income (loss) from discontinued operations		—			—			(154	)		455			—			301
Equity in earnings of consolidated subsidiaries net of income taxes		8,955			22,054			1,073			—			(32,082	)		—

Net income (loss)		8,964			8,955			19,067			4,060			(32,082	)		8,964
Net income (loss) attributable to non-controlling interests		(45	)		(45	)		—			—			45			(45	)

Net income attributable to MPT common stockholders	$	8,919		$	8,910		$	19,067		$	4,060		$	(32,037	)	$	8,919

Condensed Consolidated Statements of Income

For the Nine Months Ended September 30, 2010

(in thousands)


				Subsidiary			Subsidiary			Non-Guarantor						Total
	Parent			Issuers			Guarantors			Subsidiaries			Eliminations			Consolidated
Revenues
Rent billed	$	—		$	—		$	59,011		$	10,726		$	(705	)	$	69,032
Straight-line rent		—			—			(951	)		1,420			—			469
Interest and fee income		—			5,561			12,621			8,411			(5,999	)		20,594

Total revenues		—			5,561			70,681			20,557			(6,704	)		90,095
Expenses
Real estate depreciation and amortization		—			—			15,740			2,360			—			18,100
Impairment charge		—			—			—			12,000			—			12,000
Property-related		—			5			2,020			735			(705	)		2,055
General and administrative		74			20,216			—			242			—			20,532
Acquisition expenses		—			1,314			—			—			—			1,314

Total operating expenses		74			21,535			17,760			15,337			(705	)		54,001

Operating income (loss)		(74	)		(15,974	)		52,921			5,220			(5,999	)		36,094
Other income (expense)
Interest income and other		—			—			1,494			(6	)		—			1,488
Debt refinancing costs		—			(6,556	)		—			—			—			(6,556	)
Interest expense		—			(25,706	)		(33	)		(6,366	)		5,999			(26,106	)

Net other income (expense)		—			(32,262	)		1,461			(6,372	)		5,999			(31,174	)

Income (loss) from continuing operations		(74	)		(48,236	)		54,382			(1,152	)		—			4,920
Income (loss) from discontinued operations		—			—			(561	)		8,024			—			7,463
Equity in earnings of consolidated subsidiaries net of income taxes		12,457			60,693			3,201			—			(76,351	)		—

Net income (loss)		12,383			12,457			57,022			6,872			(76,351	)		12,383
Net income (loss) attributable to non-controlling interests		(63	)		(63	)		—			—			63			(63	)

Net income attributable to MPT common stockholders	$	12,320		$	12,394		$	57,022		$	6,872		$	(76,288	)	$	12,320

Condensed Consolidated Statements of Cash Flows

For the Nine Months Ended September 30, 2010

(in thousands)


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	(1,885	)	$	(19,512	)	$	68,429		$	461		$	—		$	47,493

Investing Activities
Real estate acquired		—			—			(73,851	)		—			—			(73,851	)
Principal received on loans receivable		—			—			—			46,532			—			46,532
Proceeds from sales of real estate		—			—			—			75,000			—			75,000
Investments in and advances to subsidiaries		(231,996	)		49,874			8,711			(60,470	)		233,881			—
Investments in loans receivable and other investments		—			—			(5,000	)		(4,626	)		—			(9,626	)
Construction in progress and other		—			(13	)		(1,607	)		(13,958	)		—			(15,578	)

Net cash provided by (used in) investing activities		(231,996	)		49,861			(71,747	)		42,478			233,881			22,477

Financing Activities
Revolving credit facilities, net		—			(96,000	)		—			(41,200	)		—			(137,200	)
Additions to term debt		—			148,500			—			—			—			148,500
Payments of term debt		—			(216,145	)		—			(180	)		—			(216,325	)
Distributions paid		(54,589	)		(54,761	)		—			—			54,589			(54,761	)
Sale of common stock, net		288,470			288,470			—			—			(288,470	)		288,470
Lease deposits and other obligations to tenants		—			—			3,318			(1,085	)		—			2,233
Debt issuance costs paid and other financing activities		—			(9,713	)		—			—			—			(9,713	)

Net cash provided by financing activities		233,881			60,351			3,318			(42,465	)		(233,881	)		21,204

Increase in cash and cash equivalents for period		—			90,700			—			474			—			91,174
Cash and cash equivalents at beginning of period		—			14,814			—			493			—			15,307

Cash and cash equivalents at end of period	$	—		$	105,514		$	—		$	967		$	—		$	106,481

- Definition

The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document.

+ References + Details

Summary Of Significant Accounting Policies (Policy)	9 Months Ended
Summary Of Significant Accounting Policies (Policy)	Sep. 30, 2011
Summary Of Significant Accounting Policies [Abstract]
Unaudited Interim Condensed Consolidated Financial Statements	Unaudited Interim Condensed Consolidated Financial Statements: The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information, including rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine month periods ended September 30, 2011 are not necessarily indicative of the results that may be expected for the year ending December 31, 2011. The condensed consolidated balance sheet at December 31, 2010 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.

- Definition

Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 140
-Paragraph 46
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 2-6
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 46R
-Paragraph 14, 15
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 18
-Paragraph 5, 6, 16-19
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Principles Board Opinion (APB)
-Number 18
-Paragraph 20
-Subparagraph a(2)
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 96-16
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Emerging Issues Task Force (EITF)
-Number 97-2
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 3A
-Section 02, 03

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 02
-Paragraph k
-Article 1

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 46R
-Paragraph 4
-Subparagraph c
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Interpretation (FIN)
-Number 46R
-Paragraph 4
-Subparagraph d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 13: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 860
-SubTopic 40
-Section 45
-URI http://asc.fasb.org/section&trid=2197723

Reference 14: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2197480

Reference 15: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6921930&loc=d3e5614-111684

Reference 16: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.3A-02)
-URI http://asc.fasb.org/extlink&oid=6959686&loc=d3e355033-122828

Reference 17: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-URI http://asc.fasb.org/subtopic&trid=2196966

Reference 18: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 45
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=6382870&loc=d3e33801-111570

Reference 19: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 325
-SubTopic 20
-URI http://asc.fasb.org/subtopic&trid=2197087

+ Details

Real Estate And Lending Activities (Tables)

9 Months Ended

Sep. 30, 2011

Real Estate And Lending Activities [Abstract]

List Of Assets Purchased As Part Of Acquisitions


	2011		2010
Land	$	17,218	$	6,264
Building		178,535		61,893
Intangible lease assets — subject to amortization (weighted average useful life of 13.5 years in 2011 and 23.1 years in 2010)		15,351		5,694

Total	$	211,104	$	73,851

Unaudited Pro forma Consolidated Financial Data


	For the Three Months Ended September 30,				For the Nine Months Ended September 30,
	2011		2010		2011		2010
Total revenues	$	38,115	$	34,986	$	113,467	$	109,522
Net income		446		11,551		17,161		12,710
Net income per share/unit – diluted	$	—	$	0.10	$	0.15	$	0.12

- Definition

Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.

+ References + Details

- Definition

Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 51
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141
-Paragraph 52
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Paragraph 68
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 141R
-Appendix F
-Paragraph F4
-Subparagraph e

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6972119&loc=d3e1392-128463

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6972119&loc=d3e1486-128463

+ Details

Debt (Tables)

9 Months Ended

Sep. 30, 2011

Debt [Abstract]

Summary Of Debt


	As of September 30, 2011				As of December 31, 2010
	Balance			Interest Rate	Balance			Interest Rate
Revolving credit facilities	$	39,600		Variable	$	—		Variable
2006 senior unsecured notes		125,000		Various		125,000		7.333% — 7.871%
2011 senior unsecured notes		450,000		6.875%		—
Exchangeable senior notes:
Principal amount		20,175		6.125% — 9.250%		91,175		6.125% — 9.250%
Unamortized discount		(248	)			(2,585	)

		19,927				88,590

Term loans:
Principal amount		14,486		6.200%		157,683		Various
Unamortized discount		—				(1,303	)

		14,486				156,380

	$	649,013			$	369,970

Principal Payments Due For Debt


2011	$	9,232
2012		39,832
2013		11,249
2014		265
2015		283
Thereafter		588,400

Total	$	649,261

Fair Value Of Financial Instruments (Tables)

9 Months Ended

Sep. 30, 2011

Fair Value Of Financial Instruments [Abstract]

Summarizes Fair Value Information Of Financial Instruments


	September 30, 2011						December 31, 2010
Asset (Liability)	Book Value			Fair Value			Book Value			Fair Value
Interest and rent receivables	$	28,822		$	22,418		$	26,176		$	20,265
Loans		221,131			223,556			215,985			209,126
Debt, net		(649,013	)		(597,802	)		(369,970	)		(359,910	)

- Definition

Tabular disclosure of the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments, assets, and liabilities. Such certain disclosures about the financial instruments, assets, and liabilities include: (1) the fair value of the required items together with their carrying amounts (as appropriate) and (2) the methodology and assumptions used in developing such estimates of fair value.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 10
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 14
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 107
-Paragraph 15
-Subparagraph b-d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 157
-Paragraph 32
-Subparagraph a, c(1), c(2), c(3), d
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 159
-Paragraph 18
-Subparagraph c(2), d, e, f
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 159
-Paragraph 19
-Subparagraph a, b, c(1), d(1)
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 10
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13433-108611

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13467-108611

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 12
-URI http://asc.fasb.org/extlink&oid=6947722&loc=d3e13476-108611

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612

Reference 11: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6925170&loc=d3e19207-110258

Reference 12: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=6447952&loc=d3e13220-108610

+ Details

Discontinued Operations (Tables)

9 Months Ended

Sep. 30, 2011

Discontinued Operations [Abstract]

Effects Of Discontinued Operations


	For the Three Months Ended September 30,					For the Nine Months Ended September 30,
	2011			2010		2011		2010
Revenues	$	—		$	572	$	—	$	4,264
Gain on sale		—			—		5		6,178
Income (loss)		(6	)		301		141		7,463
Earnings per share/unit — diluted	$	—		$	—	$	—	$	0.08

- Definition

Tabular disclosure of disposal groups, which may include the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss), amounts of revenues and pretax profit or loss reported in discontinued operations, the classification and carrying value of the assets and liabilities comprising the disposal group, and the segment in which the disposal group was reported. Also may include the amount of adjustments to amounts previously reported in discontinued operations such as resolution of contingencies arising from the disposal transaction or the operations of the component prior to disposal.

+ References + Details

Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2011

Calculation Of Earnings Per Share

		$(000,000)			$(000,000)
	For the Three Months Ended September 30,
	2011			2010
Numerator:
Income (loss) from continuing operations	$	474		$	8,663
Non-controlling interests' share in continuing operations		(43	)		(45	)
Participating securities' share in earnings		(264	)		(316	)

Income (loss) from continuing operations, less participating securities' share in earnings		167			8,302
Income (loss) from discontinued operations attributable to MPT common stockholders		(6	)		301

Net income, less participating securities' share in earnings	$	161		$	8,603

Denominator
Basic weighted-average common shares		110,714			110,046
Dilutive share options		5			—

Dilutive weighted-average common shares		110,719			110,046

		$(000,000)			$(000,000)
	For the Nine Months Ended September 30,
	2011			2010
Numerator:
Income (loss) from continuing operations	$	13,834		$	4,920
Non-controlling interests' share in continuing operations		(131	)		(63	)
Participating securities' share in earnings		(860	)		(994	)

Income (loss) from continuing operations, less participating securities' share in earnings		12,843			3,863
Income (loss) from discontinued operations attributable to MPT common stockholders		141			7,463

Net income, less participating securities' share in earnings	$	12,984		$	11,326


Denominator
Basic weighted-average common shares		110,568			97,573
Dilutive share options		8			2

Dilutive weighted-average common shares		110,576			97,575

MPT Operating Partnership L.P. [Member]

Calculation Of Earnings Per Share

		$(000,000)			$(000,000)
	For the Three Months Ended September 30,
	2011			2010
Numerator:
Income (loss) from continuing operations	$	492		$	8,654
Non-controlling interests' share in continuing operations		(43	)		(45	)
Participating securities' share in earnings		(264	)		(316	)

Income (loss) from continuing operations, less participating securities' share in earnings		185			8,293
Income (loss) from discontinued operations attributable to MPT Operating Partnership partners		(6	)		301

Net income, less participating securities' share in earnings	$	179		$	8,594


Denominator
Basic weighted-average units		110,714			110,046
Dilutive options		5			—

Dilutive weighted-average units		110,719			110,046

		$(000,000)			$(000,000)
	For the Nine Months Ended September 30,
	2011			2010
Numerator:
Income (loss) from continuing operations	$	13,896		$	4,994
Non-controlling interests' share in continuing operations		(131	)		(63	)
Participating securities' share in earnings		(860	)		(994	)

Income (loss) from continuing operations, less participating securities' share in earnings		12,905			3,937
Income (loss) from discontinued operations attributable to MPT Operating Partnership partners		141			7,463

Net income, less participating securities' share in earnings	$	13,046		$	11,400


Denominator
Basic weighted-average units		110,568			97,573
Dilutive options		8			2

Dilutive weighted-average units		110,576			97,575

Comprehensive Income (Loss) (Tables)

9 Months Ended

Sep. 30, 2011

Summary Of Comprehensive Income (Loss)

		$(000,000)			$(000,000)
	For the Three Months Ended September 30,
	2011			2010
Net income	$	468		$	8,964
Other comprehensive income (loss):
Unrealized loss on interest rate swap		(5,272	)		(3,845	)

Total comprehensive income (loss)		(4,804	)		5,119
Comprehensive income attributable to non-controlling interests		(43	)		(45	)

Comprehensive income (loss) attributable to MPT common stockholders	$	(4,847	)	$	5,074

		$(000,000)			$(000,000)
	For the Nine Months Ended September 30,
	2011			2010
Net income	$	13,975		$	12,383
Other comprehensive income (loss):
Unrealized loss on interest rate swap		(8,341	)		(7,005	)

Total comprehensive income (loss)		5,634			5,378
Comprehensive income attributable to non-controlling interests		(131	)		(63	)

Comprehensive income (loss) attributable to MPT common stockholders	$	5,503		$	5,315

MPT Operating Partnership L.P. [Member]

Summary Of Comprehensive Income (Loss)

		$(000,000)			$(000,000)
	For the Three Months Ended September 30,
	2011			2010
Net income	$	486		$	8,955
Other comprehensive income (loss):
Unrealized loss on interest rate swap		(5,272	)		(3,845	)

Total comprehensive income (loss)		(4,786	)		5,110
Comprehensive income attributable to non-controlling interests		(43	)		(45	)

Comprehensive income (loss) attributable to MPT Operating Partnership partners	$	(4,829	)	$	5,065

		$(000,000)			$(000,000)
	For the Nine Months Ended September 30,
	2011			2010
Net income	$	14,037		$	12,457
Other comprehensive income (loss):
Unrealized loss on interest rate swap		(8,341	)		(7,005	)

Total comprehensive income (loss)		5,696			5,452
Comprehensive income attributable to non-controlling interests		(131	)		(63	)

Comprehensive income (loss) attributable to MPT Operating Partnership partners	$	5,565		$	5,389

Condensed Consolidating Financial Information (Tables)

3 Months Ended

9 Months Ended

12 Months Ended

Sep. 30, 2011

Sep. 30, 2010

Sep. 30, 2011

Sep. 30, 2010

Dec. 31, 2010

Condensed Consolidating Financial Information [Abstract]

Summary Of Condensed Consolidated Balance Sheet


	Parent		Subsidiary Issuers		Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Assets
Real estate assets
Land, buildings and improvements and intangible lease assets	$	—	$	86	$	1,087,256		$	170,946		$	—		$	1,258,288
Mortgage loans		—		—		165,000			—			—			165,000

Gross investment in real estate assets		—		86		1,252,256			170,946			—			1,423,288
Accumulated depreciation and amortization		—		—		(87,681	)		(13,091	)		—			(100,772	)

Net investment in real estate assets				86		1,164,575			157,855			—			1,322,516
Cash & cash equivalents		—		113,132		—			1,236			—			114,368
Interest and rent receivable		—		505		22,184			6,133			—			28,822
Straight-line rent receivable		—		—		25,158			9,445			—			34,603
Other loans		—		177		230			55,724			—			56,131
Net intercompany receivable (payable)		21,923		869,106		(856,530	)		(34,499	)		—			—
Investment in subsidiaries		838,099		462,310		43,020			—			(1,343,429	)		—
Other assets		—		21,794		1,199			16,256			—			39,249

Total Assets	$	860,022	$	1,467,110	$	399,836		$	212,150		$	(1,343,429	)	$	1,595,689


Liabilities and Equity
Liabilities
Debt, net	$	—	$	594,927	$	—		$	54,086		$	—		$	649,013
Accounts payable and accrued expenses		22,358		33,481		1,416			411			—			57,666
Deferred revenue		—		603		18,277			4,696			—			23,576
Lease deposits and other obligations to tenants		—		—		26,641			1,129			—			27,770

Total liabilities		22,358		629,011		46,334			60,322			—			758,025
Total Medical Properties Trust Inc. stockholder's equity		837,564		837,999		353,502			151,828			(1,343,329	)		837,564

Non-controlling interests		100		100		—			—			(100	)		100

Total equity		837,664		838,099		353,502			151,828			(1,343,429	)		837,664

Total Liabilities and Equity	$	860,022	$	1,467,110	$	399,836		$	212,150		$	(1,343,429	)	$	1,595,689


	Parent		Subsidiary Issuers		Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated

Assets
Real estate assets
Land, buildings and improvements and intangible lease assets	$	—	$	297	$	903,630		$	128,442		$	—		$	1,032,369
Mortgage loans		—		—		165,000			—			—			165,000

Gross investment in real estate assets		—		297		1,068,630			128,442			—			1,197,369
Accumulated depreciation and amortization		—		—		(65,767	)		(10,327	)		—			(76,094	)

Net investment in real estate assets		—		297		1,002,863			118,115			—			1,121,275
Cash & cash equivalents		—		96,822		—			1,586			—			98,408
Interest and rent receivable		—		157		20,727			5,292			—			26,176
Straight-line rent receivable		—		—		21,180			7,732			—			28,912
Other loans		—		178		—			50,807			—			50,985
Net intercompany receivable (payable)		21,944		774,771		(767,395	)		(29,320	)		—			—
Investment in subsidiaries		899,949		390,232		42,970			—			(1,333,151	)		—
Other assets		—		10,289		1,215			11,554			—			23,058

Total Assets	$	921,893	$	1,272,746	$	321,560		$	165,766		$	(1,333,151	)	$	1,348,814


Liabilities and Equity
Liabilities
Debt, net	$	—	$	361,537	$	—		$	8,433		$	—		$	369,970
Accounts payable and accrued expenses		22,317		10,824		2,430			403			—			35,974
Deferred revenue		—		436		17,826			4,875			—			23,137
Lease deposits and other obligations to tenants		—		—		18,539			1,618			—			20,157

Total liabilities		22,317		372,797		38,795			15,329			—			449,238

Total Medical Properties Trust Inc. stockholder's equity		899,462		899,835		282,765			150,437			(1,333,037	)		899,462

Non-controlling interests		114		114		—			—			(114	)		114

Total equity		899,576		899,949		282,765			150,437			(1,333,151	)		899,576

Total Liabilities and Equity	$	921,893	$	1,272,746	$	321,560		$	165,766		$	(1,333,151	)	$	1,348,814

Summary Of Condensed Consolidated Statement Of Income


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	26,608	$	4,461		$	(331	)	$	30,738
Straight-line rent		—			—			1,255		547			—			1,802
Interest and fee income		—			1,351			4,000		1,088			(1,188	)		5,251

Total revenues		—			1,351			31,863		6,096			(1,519	)		37,791
Expenses
Real estate depreciation and amortization		—			—			7,455		975			—			8,430
Impairment charge		—			—			—		—			—			—
Property-related		—			87			211		345			(331	)		312
General and administrative		18			6,348			—		(630	)		—			5,736
Acquisition expenses		—			513			17		—			—			530

Total operating expenses		18			6,948			7,683		690			(331	)		15,008

Operating income (expense)		(18	)		(5,597	)		24,180		5,406			(1,188	)		22,783
Other income (expense)
Interest income and other		—			44			84		(77	)		—			51
Debt refinancing costs		—			(10,425	)		—		—			—			(10,425	)
Interest expense		—			(11,735	)		230		(1,618	)		1,188			(11,935	)

Net other income (expense)		—			(22,116	)		314		(1,695	)		1,188			(22,309	)

Income (loss) from continuing operations		(18	)		(27,713	)		24,494		3,711			—			474
Income (loss) from discontinued operations		—			—			—		(6	)		—			(6	)
Equity in earnings of consolidated subsidiaries net of income taxes		486			28,199			1,112		—			(29,797	)		—

Net income (loss)		468			486			25,606		3,705			(29,797	)		468
Net income (loss) attributable to non-controlling interests		(43	)		(43	)		—		—			43			(43	)

Net income (loss) attributable to MPT common stockholders	$	425		$	443		$	25,606	$	3,705		$	(29,754	)	$	425


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated

Revenues
Rent billed	$	—		$	—		$	20,116		$	3,682		$	(326	)	$	23,472
Straight-line rent		—			—			(1,612	)		488			—			(1,124	)
Interest and fee income		—			1,420			4,216			2,192			(1,532	)		6,296

Total revenues		—			1,420			22,720			6,362			(1,858	)		28,644
Expenses
Real estate depreciation and amortization		—			—			5,421			788			—			6,209
Impairment charge		—			—			—			—			—			—
Property-related		—			(43	)		640			329			(326	)		600
General and administrative		(9	)		5,781			—			77			—			5,849
Acquisition expenses		—			364			—			—			—			364

Total operating expenses		(9	)		6,102			6,061			1,194			(326	)		13,022

Operating income (loss)		9			(4,682	)		16,659			5,168			(1,532	)		15,622
Other income (expense)
Interest income and other		—			(17	)		1,494			(2	)		—			1,475
Debt refinancing costs		—			(342	)		—			—			—			(342	)
Interest expense		—			(8,058	)		(5	)		(1,561	)		1,532			(8,092	)

Net other income (expense)		—			(8,417	)		1,489			(1,563	)		1,532			(6,959	)

Income (loss) from continuing operations		9			(13,099	)		18,148			3,605			—			8,663
Income (loss) from discontinued operations		—			—			(154	)		455			—			301
Equity in earnings of consolidated subsidiaries net of income taxes		8,955			22,054			1,073			—			(32,082	)		—

Net income (loss)		8,964			8,955			19,067			4,060			(32,082	)		8,964
Net income (loss) attributable to non-controlling interests		(45	)		(45	)		—			—			45			(45	)

Net income attributable to MPT common stockholders	$	8,919		$	8,910		$	19,067		$	4,060		$	(32,037	)	$	8,919


	Parent			Subsidiary Issuers			Subsidiary Guarantors		Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Revenues
Rent billed	$	—		$	—		$	76,907	$	12,606		$	(994	)	$	88,519
Straight-line rent		—			—			3,891		1,715			—			5,606
Interest and fee income		—			4,118			12,677		3,105			(4,088	)		15,812

Total revenues		—			4,118			93,475		17,426			(5,082	)		109,937
Expenses
Real estate depreciation and amortization		—			—			21,914		2,764			—			24,678
Impairment charge		—			—			564		—			—			564
Property-related		—			87			513		1,023			(994	)		629
General and administrative		62			18,356			—		2,010			—			20,428
Acquisition expenses		—			2,717			469		—			—			3,186

Total operating expenses		62			21,160			23,460		5,797			(994	)		49,485

Operating income (expense)		(62	)		(17,042	)		70,015		11,629			(4,088	)		60,452
Other income (expense)
Interest income and other		—			42			84		(68	)		—			58
Debt refinancing costs		—			(14,109	)		—		(105	)		—			(14,214	)
Interest expense		—			(31,750	)		488		(5,288	)		4,088			(32,462	)

Net other income (expense)		—			(45,817	)		572		(5,461	)		4,088			(46,618	)

Income (loss) from continuing operations		(62	)		(62,859	)		70,587		6,168			—			13,834
Income (loss) from discontinued operations		—			—			98		43			—			141
Equity in earnings of consolidated subsidiaries net of income taxes		14,037			76,896			3,457		—			(94,390	)		—

Net income (loss)		13,975			14,037			74,142		6,211			(94,390	)		13,975
Net income (loss) attributable to non-controlling interests		(131	)		(131	)		—		—			131			(131	)

Net income (loss) attributable to MPT common stockholders	$	13,844		$	13,906		$	74,142	$	6,211		$	(94,259	)	$	13,844


				Subsidiary			Subsidiary			Non-Guarantor						Total
	Parent			Issuers			Guarantors			Subsidiaries			Eliminations			Consolidated
Revenues
Rent billed	$	—		$	—		$	59,011		$	10,726		$	(705	)	$	69,032
Straight-line rent		—			—			(951	)		1,420			—			469
Interest and fee income		—			5,561			12,621			8,411			(5,999	)		20,594

Total revenues		—			5,561			70,681			20,557			(6,704	)		90,095
Expenses
Real estate depreciation and amortization		—			—			15,740			2,360			—			18,100
Impairment charge		—			—			—			12,000			—			12,000
Property-related		—			5			2,020			735			(705	)		2,055
General and administrative		74			20,216			—			242			—			20,532
Acquisition expenses		—			1,314			—			—			—			1,314

Total operating expenses		74			21,535			17,760			15,337			(705	)		54,001

Operating income (loss)		(74	)		(15,974	)		52,921			5,220			(5,999	)		36,094
Other income (expense)
Interest income and other		—			—			1,494			(6	)		—			1,488
Debt refinancing costs		—			(6,556	)		—			—			—			(6,556	)
Interest expense		—			(25,706	)		(33	)		(6,366	)		5,999			(26,106	)

Net other income (expense)		—			(32,262	)		1,461			(6,372	)		5,999			(31,174	)

Income (loss) from continuing operations		(74	)		(48,236	)		54,382			(1,152	)		—			4,920
Income (loss) from discontinued operations		—			—			(561	)		8,024			—			7,463
Equity in earnings of consolidated subsidiaries net of income taxes		12,457			60,693			3,201			—			(76,351	)		—

Net income (loss)		12,383			12,457			57,022			6,872			(76,351	)		12,383
Net income (loss) attributable to non-controlling interests		(63	)		(63	)		—			—			63			(63	)

Net income attributable to MPT common stockholders	$	12,320		$	12,394		$	57,022		$	6,872		$	(76,288	)	$	12,320

Summary Of Condensed Consolidated Statements Of Cash Flows


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	(124	)	$	(26,727	)	$	86,972		$	7,007		$	—		$	67,128

Investing Activities
Real estate acquired		—			—			(168,600	)		(27,911	)		—			(196,511	)
Principal received on loans receivable		—			—			—			2,898			—			2,898
Proceeds from sales of real estate		—			—			—			—			—			—
Investments in and advances to subsidiaries		67,126			(89,763	)		89,135			504			(67,002	)		—
Investments in loans receivable and other investments		—			(205	)		(3,314	)		(13,281	)		—			(16,800	)
Construction in progress and other		—			—			(12,297	)		—			—			(12,297	)

Net cash provided by (used in) investing activities		67,126			(89,968	)		(95,076	)		(37,790	)		(67,002	)		(222,710	)

Financing Activities
Revolving credit facilities, net		—			—			—			39,600			—			39,600
Additions to term debt		—			450,000			—			—			—			450,000
Payments of term debt		—			(229,271	)		—			(8,539	)		—			(237,810	)
Distributions paid		(67,002	)		(67,194	)		—			—			67,002			(67,194	)
Sale of common stock, net		—			—			—			—			—			—
Lease deposits and other obligations to tenants		—			—			8,104			(491	)		—			7,613
Debt issuance costs paid and other financing activities		—			(20,530	)		—			(137	)		—			(20,667	)

Net cash provided by financing activities		(67,002	)		133,005			8,104			30,433			67,002			171,542

Increase (decrease) in cash and cash equivalents for period		—			16,310			—			(350	)		—			15,960
Cash and cash equivalents at beginning of period		—			96,822			—			1,586			—			98,408

Cash and cash equivalents at end of period	$	—		$	113,132		$	—		$	1,236		$	—		$	114,368


	Parent			Subsidiary Issuers			Subsidiary Guarantors			Non-Guarantor Subsidiaries			Eliminations			Total Consolidated
Operating Activities
Net cash provided by (used in) operating activities	$	(1,885	)	$	(19,512	)	$	68,429		$	461		$	—		$	47,493

Investing Activities
Real estate acquired		—			—			(73,851	)		—			—			(73,851	)
Principal received on loans receivable		—			—			—			46,532			—			46,532
Proceeds from sales of real estate		—			—			—			75,000			—			75,000
Investments in and advances to subsidiaries		(231,996	)		49,874			8,711			(60,470	)		233,881			—
Investments in loans receivable and other investments		—			—			(5,000	)		(4,626	)		—			(9,626	)
Construction in progress and other		—			(13	)		(1,607	)		(13,958	)		—			(15,578	)

Net cash provided by (used in) investing activities		(231,996	)		49,861			(71,747	)		42,478			233,881			22,477

Financing Activities
Revolving credit facilities, net		—			(96,000	)		—			(41,200	)		—			(137,200	)
Additions to term debt		—			148,500			—			—			—			148,500
Payments of term debt		—			(216,145	)		—			(180	)		—			(216,325	)
Distributions paid		(54,589	)		(54,761	)		—			—			54,589			(54,761	)
Sale of common stock, net		288,470			288,470			—			—			(288,470	)		288,470
Lease deposits and other obligations to tenants		—			—			3,318			(1,085	)		—			2,233
Debt issuance costs paid and other financing activities		—			(9,713	)		—			—			—			(9,713	)

Net cash provided by financing activities		233,881			60,351			3,318			(42,465	)		(233,881	)		21,204

Increase in cash and cash equivalents for period		—			90,700			—			474			—			91,174
Cash and cash equivalents at beginning of period		—			14,814			—			493			—			15,307

Cash and cash equivalents at end of period	$	—		$	105,514		$	—		$	967		$	—		$	106,481

Real Estate And Lending Activities (Narrative) (Details) $ in Thousands	1 Months Ended	3 Months Ended					9 Months Ended
	Apr. 30, 2010 USD ($)	Sep. 30, 2011 USD ($) years	Jun. 30, 2011 USD ($)	Sep. 30, 2010 USD ($)	Jun. 30, 2010 USD ($)	Mar. 31, 2010 USD ($)	Sep. 30, 2011 USD ($) years	Sep. 30, 2010 USD ($)	Nov. 04, 2011 USD ($)
Real Estate And Lending Activities [Line Items]
Purchase price of real estate		$ 211,104		$ 73,851			$ 211,104	$ 73,851
Gain on sale of real estate							5	7,693
Billed rent		1,500					1,500
Unbilled rent		200					200
Promissory note		700					700
Other receivables due from tenant		100					100
Impairment charges against real estate			$ 600
Payments received from the tenant		200
Income contributed by the acquired entity		446		$ 11,551			$ 17,161	12,710
Lease expiration date							March 2010
Aggregate purchase price								74,000
Existing mortgage loan		$ 16,000					$ 16,000
Mortgage loan maturity date							Jan. 01, 2018
Ownership interest in equity		99.90%					99.90%		100.00%
Advanced amount of working capital loan agreement									$ 600
Gain resulted in exchange of real estate property								1,300
Straight line rent receivables write off								$ 200
Inpatient Rehabilitation Hospitals [Member]
Real Estate And Lending Activities [Line Items]
Date acquired								June 17, 2010
Vibra Specialty Hospital [Member]
Real Estate And Lending Activities [Line Items]
Date acquired							July 18, 2011
Number of beds acquired		40					40
Equity investments		$ 2,500					$ 2,500
Ownership interest in equity		25.00%					25.00%
Prime Health Care Services [Member]
Real Estate And Lending Activities [Line Items]
Term of lease, years					10
Additional rent received from lease agreement					$ 12,000
Estimated future rent amount expected from lease agreement					$ 20,000
Income expected to recognize from remaining lease period			$ 8,500				$ 3,500
Percentage of entity revenue from affiliates		30.90%		33.80%			31.10%	33.40%
Date of loan repayment							April 2010
Repayment of loans and accrued interest from affiliates							$ 40,000
Vibra Health Care [Member]
Real Estate And Lending Activities [Line Items]
Percentage of entity revenue from affiliates		12.40%		15.40%			12.60%	14.70%
Acute Care Facility [Member]
Real Estate And Lending Activities [Line Items]
Date acquired							September 30, 2011
Number of beds acquired		40					40
Equity investments		$ 1,400					$ 1,400
Ownership interest in equity		25.00%					25.00%
Monroe Hospital [Member]
Real Estate And Lending Activities [Line Items]
Revenue contributed by the acquired entity							$ 14,600
Advanced amount of working capital loan agreement		$ 28,800					28,800
Interest receivable		5,500					5,500
Impairment of working capital loan recognized						$ 12,000
Valuation allowance for rent							2,500
Impairment of working capital loan estimation-cash balance considered for first priority secured interest							$ 4,000
Impairment of working capital loan estimation-membership interest of operator/lessee considered for first priority secured interest							100.00%
Net investment to maximum exposure		31,400					$ 31,400
Impairment of working capital loan estimation-patient receivables considered for first priority secured interest							7,000
Denham Springs Facility [Member]
Real Estate And Lending Activities [Line Items]
Purchase price of real estate		4,400					$ 4,400
Business Acquisitions [Member]
Real Estate And Lending Activities [Line Items]
Number of business acquisitions in period							7
Revenue contributed by the acquired entity		5,500					$ 14,000
Income contributed by the acquired entity		$ 3,700					$ 9,100
Ownership interest in equity		51.00%					51.00%
Retained ownership in operating entity							49.00%
Working capital loan to the joint venture							$ 5,200
Acquisition related costs		$ 500					$ 3,200
Business Acquisitions [Member] \| Gilbert Hospital [Member]
Real Estate And Lending Activities [Line Items]
Date acquired							January 4, 2011
Number of beds acquired		19					19
Age of real estate acquired \| years		4					4
Purchase price of real estate		$ 17,100					$ 17,100
Lease expiration date							May 2022
Business Acquisitions [Member] \| Atrium Medical Center [Member]
Real Estate And Lending Activities [Line Items]
Date acquired							January 31, 2011
Number of beds acquired		60					60
Purchase price of real estate		$ 23,500					$ 23,500
Date of construction							2009
Lease expiration date							June 2024
Business Acquisitions [Member] \| Bayonne Medical Center [Member]
Real Estate And Lending Activities [Line Items]
Date acquired							February 4, 2011
Number of beds acquired		278					278
Term of lease, years		15					15
Number of lease extension options in current lease contract		6					6
Term of lease extension, years		5					5
Purchase price of real estate		$ 58,000					$ 58,000
Business Acquisitions [Member] \| Alvarado Hospital [Member]
Real Estate And Lending Activities [Line Items]
Date acquired							February 9, 2011
Number of beds acquired		306					306
Term of lease, years		10					10
Purchase price of real estate		$ 70,000					$ 70,000
Business Acquisitions [Member] \| Northland LTACH Hospital [Member]
Real Estate And Lending Activities [Line Items]
Date acquired							February 14, 2011
Number of beds acquired		35					35
Purchase price of real estate		$ 19,500					$ 19,500
Date of construction							April 2008
Lease expiration date							2028
Existing mortgage loan		$ 16,000					$ 16,000
Business Acquisitions [Member] \| Vibra Specialty Hospital [Member]
Real Estate And Lending Activities [Line Items]
Term of lease extension, years		15					15
Purchase price of real estate		$ 13,000					$ 13,000
Business Acquisitions [Member] \| Vibra Health Care [Member]
Real Estate And Lending Activities [Line Items]
Payments to acquire equity method investments							$ 1,300
Ownership interest in equity		19.00%					19.00%
Business Acquisitions [Member] \| Acute Care Facility [Member]
Real Estate And Lending Activities [Line Items]
Term of lease extension, years		15					15
Purchase price of real estate		$ 10,000					$ 10,000
Working capital loan to the joint venture							$ 2,000
Business Acquisitions [Member] \| Rehabilitation Hospitals [Member]
Real Estate And Lending Activities [Line Items]
Term of lease extension, years		10					10
Revenue contributed by the acquired entity				$ 1,900				$ 2,200
Income contributed by the acquired entity				1,400				$ 1,700
Lease expiration date								2033
Acquisition related costs				$ 400				$ 1,300
Business Disposals [Member] \| Centinela Hospital [Member]
Real Estate And Lending Activities [Line Items]
Date disposed		April 2010					April 2010
Number of beds acquired	369
Selling price of real estate	$ 75,000
Gain on sale of real estate	$ 6,000
Leasing Operations [Member] \| Covington [Member]
Real Estate And Lending Activities [Line Items]
Term of lease, years		15					15
Number of lease extension options in current lease contract		3					3
Term of lease extension, years		5					5
Rate of increase in annual rent							2.00%
Revenue contributed by the acquired entity							$ 1,400

Real Estate And Lending Activities (List Of Assets Purchased As Part Of Acquisitions) (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2011 USD ($)	Sep. 30, 2010 USD ($)
Real Estate Assets Purchased As Part Of Acquisitions [Line Items]
Total	$ 211,104	$ 73,851
Land [Member]
Real Estate Assets Purchased As Part Of Acquisitions [Line Items]
Significant acquisitions and disposals of acquisition	17,218	6,264
Building [Member]
Real Estate Assets Purchased As Part Of Acquisitions [Line Items]
Significant acquisitions and disposals of acquisition	178,535	61,893
Intangible Lease Assets [Member]
Real Estate Assets Purchased As Part Of Acquisitions [Line Items]
Significant acquisitions and disposals of acquisition	$ 15,351	$ 5,694
Weighted average life of acquired intangible assets (in years)	13.5	23.1

Real Estate And Lending Activities (Unaudited Pro forma Consolidated Financial Data) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Real Estate And Lending Activities [Abstract]
Total revenues	$ 38,115	$ 34,986	$ 113,467	$ 109,522
Net income	$ 446	$ 11,551	$ 17,161	$ 12,710
Net income per share/unit - diluted		$ 0.10	$ 0.15	$ 0.12

Debt (Narrative) (Details) - USD ($)	1 Months Ended			3 Months Ended			9 Months Ended		12 Months Ended
Debt (Narrative) (Details) - USD ($)	Apr. 30, 2011	May 31, 2010	Apr. 30, 2010	Sep. 30, 2011	Sep. 30, 2010	Jun. 30, 2010	Sep. 30, 2011	Sep. 30, 2010	Dec. 31, 2010
Debt Instrument [Line Items]
Mortgage loan assumed, value				$ 16,000,000			$ 16,000,000
Mortgage loan assumed, term, years							30
Mortgage loan assumed, interest rate							6.20%
Mortgage loan assumed, maturity date							Jan. 01, 2018
Mortgage loan assumed, date prepayment restriction expires							January 1, 2013
Unsecured senior notes, value of private offering	$ 450,000,000
Unsecured senior notes, interest rate	6.875%
Unsecured senior notes, year of maturity	2021
Repaid and terminated term loan facility							$ 237,810,000	$ 216,325,000
Repaid and terminated collateralized term loan	$ 9,000,000
Revolving credit facility, amended	$ 330,000,000
Unsecured revolving credit facility maturity	October 2015
Federal funds rate spread	1.60%
LIBOR plus spread interest rate	2.60%
Percentage of outstanding notes purchased from senior unsecured notes offering				86.60%
Exchangeable senior notes due date				2013
Price of principal amount plus accrued and unpaid interest, in percentage				118.40%
Price of principal amount plus accrued and unpaid interest, in amount				$ 84,100,000
Public offering of common stock net proceeds, after underwriting discount and commissions			$ 279,000,000
Paid off term loan							30,000,000
Closed credit facility		$ 450,000,000
Charge of refinancing activities				10,400,000	$ 300,000		14,200,000	6,600,000
Interest rate swap, amount fixed						$ 65,000,000
Total senior notes available				649,013,000		$ 125,000,000	649,013,000		$ 369,970,000
Maturity date of interest rate swap						July 2016
Hedge ineffectiveness and income statement effect in period				0	$ 0		$ 0	0
Dividend rate as percentage of normalized adjusted funds from operations							95.00%
Parent [Member]
Debt Instrument [Line Items]
Repaid and terminated term loan facility
Interest Rate Contract [Member]
Debt Instrument [Line Items]
Fair value of the interest rate swaps				12,000,000			$ 12,000,000
Interest Rate Contract One [Member]
Debt Instrument [Line Items]
Interest rate of interest rate derivative instrument							5.507%
Interest Rate Contract Two [Member]
Debt Instrument [Line Items]
Interest rate swap, amount fixed				$ 60,000,000			$ 60,000,000
Interest rate of interest rate derivative instrument							5.675%
2006 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Unsecured senior notes, interest rate				2.67%			2.67%
Debt Instrument, Interest Rate, Stated Percentage Rate Range, Minimum							7.333%		7.333%
Debt Instrument, Interest Rate, Stated Percentage Rate Range, Maximum							7.715%		7.871%
Debt face amount				$ 125,000,000			$ 125,000,000		$ 125,000,000
Fixed rate, minimum							7.333%		7.333%
Fixed rate, maximum							7.715%		7.871%
Exchangeable Senior Notes [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage Rate Range, Minimum							6.125%		6.125%
Debt Instrument, Interest Rate, Stated Percentage Rate Range, Maximum							9.25%		9.25%
Debt face amount				$ 20,175,000			$ 20,175,000		$ 91,175,000
Fixed rate, minimum							6.125%		6.125%
Fixed rate, maximum							9.25%		9.25%
Term Loans [Member]
Debt Instrument [Line Items]
Unsecured senior notes, interest rate				6.20%			6.20%
Repaid and terminated term loan facility	$ 150,000,000
Debt face amount				$ 14,486,000			$ 14,486,000		$ 157,683,000
Revolving Credit Facilities [Member]
Debt Instrument [Line Items]
Debt face amount				$ 39,600,000			39,600,000
6.125% Exchangeable Senior Notes [Member]
Debt Instrument [Line Items]
Percentage of outstanding notes purchased from senior unsecured notes offering			93.00%
Exchangeable senior notes due date			2011
Price of principal amount plus accrued and unpaid interest, in percentage			103.00%
Price of principal amount plus accrued and unpaid interest, in amount			$ 136,300,000
Federal Funds Rate [Member]
Debt Instrument [Line Items]
Unsecured senior notes, interest rate	0.50%
Maximum [Member]
Debt Instrument [Line Items]
Federal funds rate spread	2.40%
LIBOR plus spread interest rate	3.40%
Minimum [Member]
Debt Instrument [Line Items]
Federal funds rate spread	1.60%
LIBOR plus spread interest rate	2.60%
Fixed Interest Rate Range 7.333% To 7.715% [Member] \| 2006 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Portion of debt instrument face amount							60,000,000
Variable Interest Rate 5.507% [Member] \| 2006 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Portion of debt instrument face amount							$ 65,000,000

Debt (Summary Of Debt) (Details) - USD ($)	9 Months Ended	12 Months Ended
Debt (Summary Of Debt) (Details) - USD ($)	Sep. 30, 2011	Dec. 31, 2010	Apr. 30, 2011	Jun. 30, 2010
Debt Instrument [Line Items]
Total senior notes available	$ 649,013,000	$ 369,970,000		$ 125,000,000
Unsecured senior notes, interest rate			6.875%
Revolving Credit Facilities [Member]
Debt Instrument [Line Items]
Principal amount	39,600,000
2006 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Principal amount	$ 125,000,000	$ 125,000,000
Unsecured senior notes, interest rate	2.67%
Interest rate, minimum	7.333%	7.333%
Interest rate, maximum	7.715%	7.871%
2011 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Principal amount	$ 450,000,000
Unsecured senior notes, interest rate	6.875%
Exchangeable Senior Notes [Member]
Debt Instrument [Line Items]
Principal amount	$ 20,175,000	91,175,000
Unamortized discount	(248,000)	(2,585,000)
Debt instrument, net	$ 19,927,000	$ 88,590,000
Interest rate, minimum	6.125%	6.125%
Interest rate, maximum	9.25%	9.25%
Term Loans [Member]
Debt Instrument [Line Items]
Principal amount	$ 14,486,000	$ 157,683,000
Unamortized discount		(1,303,000)
Debt instrument, net	$ 14,486,000	$ 156,380,000
Unsecured senior notes, interest rate	6.20%
Interest rate terms		Various

Debt (Principal Payments Due For Debt) (Details) $ in Thousands	Sep. 30, 2011 USD ($)
Debt [Abstract]
2011	$ 9,232
2012	39,832
2013	11,249
2014	265
2015	283
Thereafter	588,400
Total	$ 649,261

Common Stock (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	1 Months Ended	3 Months Ended	9 Months Ended
	Apr. 30, 2010	Mar. 31, 2010	Sep. 30, 2010	Sep. 30, 2011	Dec. 31, 2010
Common stock, shares issued				110,647	110,225
Proceeds from issuance of common stock			$ 288,470
Public Offering [Member]
Common stock, shares issued	26,000
Public offering price for common stock per share	$ 9.75
Underwriters' purchase of shares to cover over allotments	3,900
Proceeds from issuance of common stock	$ 279,000
Market Equity Offering Program [Member]
Common stock, shares issued		900
Proceeds from issuance of common stock		$ 9,500
Average price of common stock under market equity offering program per share		$ 10.77
Sales commission		2.00%
Parent [Member]
Proceeds from issuance of common stock			$ 288,470

Stock Awards (Details) - shares	3 Months Ended			9 Months Ended
Stock Awards (Details) - shares	Sep. 30, 2011	Mar. 31, 2011	Sep. 30, 2010	Sep. 30, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reserved shares of common stock for awards under the Equity Incentive Plan	7,441,180			7,441,180
Common stock remaining for future stock awards	2,642,597			2,642,597
Stock award vesting period in years		two
Time-Based Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, shares issued	269,085		277,680
Stock award vesting period in years				three
Performance-Based Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, shares issued	229,938		182,600
Stock award vesting period in years				three
Multi-Year Performance-Based Awards [member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, multi-year performance based-awards		600,000
Stock award vesting period in years		three

Partner's Capital (Details)	Nov. 04, 2011	Sep. 30, 2011
Partners' Capital [Abstract]
Limited partners including the Company		100.00%
Ownership interest in Operating Partnership	100.00%	99.90%

Fair Value Of Financial Instruments (Summary Of Fair Value Information Of Financial Instruments) (Details) - USD ($) $ in Thousands	Sep. 30, 2011	Dec. 31, 2010	Jun. 30, 2010
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest and rent receivables	$ 28,822	$ 26,176
Loans	221,131	215,985
Debt, net	(649,013)	(369,970)	$ (125,000)
Fair Value [member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Interest and rent receivables	22,418	20,265
Loans	223,556	209,126
Debt, net	$ (597,802)	$ (359,910)

Discontinued Operations (Narrative) (Details) $ in Thousands	1 Months Ended		9 Months Ended	12 Months Ended
	Oct. 31, 2010 USD ($)	Apr. 30, 2010 USD ($)	Sep. 30, 2010 USD ($)	Dec. 31, 2010 USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sale of real estate			$ 75,000
Number of beds sold		369
Montclair Hospital [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sale of real estate				$ 20,000
Gain on sale of real estate				$ 2,200
Sharpstown Hospital [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sale of real estate	$ 3,000
Gain on sale of real estate	$ 700
Centinela Hospital [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Sale of real estate		$ 75,000
Gain on sale of real estate		$ 6,000

Discontinued Operations (Effects Of Discontinued Operations) (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Discontinued Operations [Abstract]
Revenues		$ 572		$ 4,264
Gain on sale			$ 5	6,178
Income (loss)	$ (6)	$ 301	$ 141	$ 7,463
Earnings per share/unit - diluted				$ 0.08

- Definition

Gain (loss) after tax expense or benefit, not previously recognized and resulting from the sale of a business component, which is recognized at the date of sale. A gain (loss) reflects the amount by which the consideration received exceeds (is exceeded by) the net carrying amount (reflecting previous provisions for loss on disposal, if any) of the disposal group.

+ References + Details

- Definition

This element represents the overall income (loss) from a disposal group that is classified as a component of the entity, net of income tax, reported as a separate component of income before extraordinary items before deduction or consideration of the amount which may be allocable to noncontrolling interests, if any. Includes the following (net of tax): income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 144
-Paragraph 43
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 144
-Paragraph 47
-Subparagraph c
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 29
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Article 5
-Section 03
-Paragraph 15

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-X (SX)
-Number 210
-Section 04
-Paragraph 13
-Article 7

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6892542&loc=d3e957-107759

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 225
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04.12)
-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 225
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.14)
-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

+ Details

Earnings Per Share (Calculation Of Earnings Per Share) (Details) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Income (loss) from continuing operations	$ 474	$ 8,663	$ 13,834	$ 4,920
Basic weighted-average common shares	110,714	110,046	110,568	97,573
Dilutive weighted-average common shares/units	110,719	110,046	110,576	97,575
Stock Options [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Stock options excluded from earnings per share computation	100	100	100	100
Medical Properties Trust, Inc. [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Income (loss) from continuing operations	$ 474	$ 8,663	$ 13,834	$ 4,920
Non-controlling interests' share in continuing operations	(43)	(45)	(131)	(63)
Participating securities' share in earnings	(264)	(316)	(860)	(994)
Income (loss) from continuing operations, less participating securities' share in earnings	167	8,302	12,843	3,863
Income (loss) from discontinued operations attributable to MPT common stockholders/Operating Partnership partners	(6)	301	141	7,463
Net income, less participating securities' share in earnings	$ 161	$ 8,603	$ 12,984	$ 11,326
Basic weighted-average common shares	110,714	110,046	110,568	97,573
Dilutive share options	5		8	2
Dilutive weighted-average common shares/units	110,719	110,046	110,576	97,575
MPT Operating Partnership L.P. [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Income (loss) from continuing operations	$ 492	$ 8,654	$ 13,896	$ 4,994
Non-controlling interests' share in continuing operations	(43)	(45)	(131)	(63)
Participating securities' share in earnings	(264)	(316)	(860)	(994)
Income (loss) from continuing operations, less participating securities' share in earnings	185	8,293	12,905	3,937
Income (loss) from discontinued operations attributable to MPT common stockholders/Operating Partnership partners	(6)	301	141	7,463
Net income, less participating securities' share in earnings	$ 179	$ 8,594	$ 13,046	$ 11,400
Basic weighted-average common shares	110,714	110,046	110,568	97,573
Dilutive share options	5		8	2
Dilutive weighted-average common shares/units	110,719	110,046	110,576	97,575

Comprehensive Income (Loss) (Summary Of Comprehensive Income (Loss)) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Net income	$ 468	$ 8,964	$ 13,975	$ 12,383
Medical Properties Trust, Inc. [Member]
Net income	468	8,964	13,975	12,383
Unrealized loss on interest rate swap	(5,272)	(3,845)	(8,341)	(7,005)
Total comprehensive income (loss)	(4,804)	5,119	5,634	5,378
Comprehensive income attributable to non-controlling interests	(43)	(45)	(131)	(63)
Comprehensive income (loss) attributable to MPT common stockholders	(4,847)	5,074	5,503	5,315
MPT Operating Partnership L.P. [Member]
Net income	486	8,955	14,037	12,457
Unrealized loss on interest rate swap	(5,272)	(3,845)	(8,341)	(7,005)
Total comprehensive income (loss)	(4,786)	5,110	5,696	5,452
Comprehensive income attributable to non-controlling interests	(43)	(45)	(131)	(63)
Comprehensive income (loss) attributable to MPT common stockholders	$ (4,829)	$ 5,065	$ 5,565	$ 5,389

- Definition

The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the reporting entity. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, but excludes any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 8, 9, 10, 11, 12, 13, 14
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 30
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph A5
-Appendix A

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 5
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e557-108580

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Net Income
-URI http://asc.fasb.org/extlink&oid=6518256

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Other Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=6519514

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e540-108580

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Comprehensive Income
-URI http://asc.fasb.org/extlink&oid=6508144

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph c(3)
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to noncontrolling interests, if any. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent.

+ References + Details

- Definition

The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the economic entity, including both controlling (parent) and noncontrolling interests. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, including any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent.

+ References + Details

- Definition

Change in accumulated gains and losses from derivative instrument designated and qualifying as the effective portion of cash flow hedges, net of tax effect. The after tax effect change includes an entity's share of an equity investee's Increase or Decrease in deferred hedging gains or losses.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 133
-Paragraph 46
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 130
-Paragraph 24
-Subparagraph b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 130
-Paragraph 17, 20
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 130
-Paragraph 121
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 11
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e637-108580

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 13
-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e653-108580

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 10
-Section 50
-Paragraph 4C
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5624171-113959

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 55
-Paragraph 2
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=6920433&loc=d3e998-108581

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph c(3)
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 29
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph a
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph A1, A4, A5
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 5
-Subparagraph b
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591552-111686

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI http://asc.fasb.org/extlink&oid=6921628&loc=SL4569616-111683

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI http://asc.fasb.org/extlink&oid=6922042&loc=SL4591551-111686

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a),(c)
-URI http://asc.fasb.org/extlink&oid=6921930&loc=SL4573702-111684

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher AICPA
-Name Accounting Research Bulletin (ARB)
-Number 51
-Paragraph 38
-Subparagraph c(1)
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Subsequent Events (Details) $ in Millions		1 Months Ended
Subsequent Events (Details) $ in Millions	Nov. 04, 2011 USD ($)	Oct. 31, 2011 USD ($)	Sep. 30, 2011
Number of facilities under lease term agreements		3
Expected cost for acquisition, development and lease		$ 30
Initial term period of lease term agreements (in years)	15	15
Number of extension options on term lease agreements	6	3
Extension option of term lease agreements (in years)	5	5
Real estate acquisitions	$ 75
Ownership interest in equity	100.00%		99.90%
Secured working capital loan	$ 20
Convertible note	$ 5
Hoboken University Medical Center [Member]
Number of beds acquired	350

Income Taxes (Details) $ in Millions	Jun. 30, 2010 USD ($)
Income Taxes [Abstract]
Deferred tax asset	$ 1.5
Deferred tax asset related to discontinued operations	$ 1.2

- Definition

Amount of deferred tax asset recognized pertaining to the parent company's excess tax (over book) basis in the stock of a disposed subsidiary that is a component of the entity (discontinued operation).

+ References + Details

Executive Severance (Details) - USD ($) $ in Millions	9 Months Ended
Executive Severance (Details) - USD ($) $ in Millions	Sep. 30, 2011	Sep. 30, 2010	Dec. 16, 2010	Jun. 11, 2010
Executive Severance [Abstract]
Date of announced resignation of general counsel				June 15, 2010
Additional stock compensation expense	$ 0.9
One time cash payment			$ 1.9
Severance cost included in general and administrative expense		$ 2.8

- Definition

The charge against earnings in the period for known and estimated costs of termination benefits provided to current employees that are involuntarily terminated under a benefit arrangement associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, excluding costs or losses pertaining to an entity newly acquired in a business combination or a discontinued operation as defined by generally accepted accounting principles and costs associated with one-time termination benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Staff Accounting Bulletin (SAB)
-Number Topic 5
-Section P
-Subsection 3, 4

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name FASB Staff Position (FSP)
-Number FAS146-1
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 132R
-Paragraph 5-8
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 112
-Paragraph 7
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 146
-Paragraph 8-13, 20
-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 5.P.3)
-URI http://asc.fasb.org/extlink&oid=6394695&loc=d3e140864-122747

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 5.P.4(b))
-URI http://asc.fasb.org/extlink&oid=6394695&loc=d3e140904-122747

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)(10)
-URI http://asc.fasb.org/extlink&oid=6962843&loc=d3e1928-114920

+ Details

Condensed Consolidating Financial Information (Summary Of Condensed Consolidated Balance Sheet) (Details) - USD ($) $ in Thousands	Sep. 30, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Dec. 31, 2009
Condensed Financial Statements, Captions [Line Items]
Land, buildings and improvements, and intangible lease assets	$ 1,258,288	$ 1,032,369
Mortgage loans	165,000	165,000
Gross investment in real estate assets	1,423,288	1,197,369
Accumulated depreciation and amortization	(100,772)	(76,094)
Net investment in real estate assets	1,322,516	1,121,275
Cash and cash equivalents	114,368	98,408	$ 106,481		$ 15,307
Interest and rent receivable	28,822	26,176
Straight-line rent receivable	34,603	28,912
Other loans	56,131	50,985
Other assets	39,249	23,058
Total Assets	1,595,689	1,348,814
Debt, net	649,013	369,970		$ 125,000
Accounts payable and accrued expenses	57,666	35,974
Deferred revenue	23,576	23,137
Lease deposits and other obligations to tenants	27,770	20,157
Total liabilities	758,025	449,238
Additional paid in capital	1,054,040	1,051,785
Distributions in excess of net income	(204,343)	(148,530)
Accumulated other comprehensive loss	(11,982)	(3,641)
Treasury shares, at cost	(262)	(262)
Total Medical Properties Trust, Inc. stockholders' equity	837,564	899,462
Non-controlling interests	100	114
Total Liabilities and Equity	1,595,689	1,348,814
Total equity	837,664	899,576
Parent [Member]
Condensed Financial Statements, Captions [Line Items]
Cash and cash equivalents
Net intercompany receivable (payable)	21,923	21,944
Investment in subsidiaries	838,099	899,949
Total Assets	860,022	921,893
Accounts payable and accrued expenses	22,358	22,317
Total liabilities	22,358	22,317
Total Medical Properties Trust, Inc. stockholders' equity	837,564	899,462
Non-controlling interests	100	114
Total Liabilities and Equity	860,022	921,893
Total equity	837,664	899,576
Subsidiary Issuers [Member]
Condensed Financial Statements, Captions [Line Items]
Land, buildings and improvements, and intangible lease assets	86	297
Gross investment in real estate assets	86	297
Net investment in real estate assets	86	297
Cash and cash equivalents	113,132	96,822	105,514		14,814
Interest and rent receivable	505	157
Other loans	177	178
Net intercompany receivable (payable)	869,106	774,771
Investment in subsidiaries	462,310	390,232
Other assets	21,794	10,289
Total Assets	1,467,110	1,272,746
Debt, net	594,927	361,537
Accounts payable and accrued expenses	33,481	10,824
Deferred revenue	603	436
Total liabilities	629,011	372,797
Total Medical Properties Trust, Inc. stockholders' equity	837,999	899,835
Non-controlling interests	100	114
Total Liabilities and Equity	1,467,110	1,272,746
Total equity	838,099	899,949
Subsidiary Guarantors [Member]
Condensed Financial Statements, Captions [Line Items]
Land, buildings and improvements, and intangible lease assets	1,087,256	903,630
Mortgage loans	165,000	165,000
Gross investment in real estate assets	1,252,256	1,068,630
Accumulated depreciation and amortization	(87,681)	(65,767)
Net investment in real estate assets	1,164,575	1,002,863
Cash and cash equivalents
Interest and rent receivable	22,184	20,727
Straight-line rent receivable	25,158	21,180
Other loans	230
Net intercompany receivable (payable)	(856,530)	(767,395)
Investment in subsidiaries	43,020	42,970
Other assets	1,199	1,215
Total Assets	399,836	321,560
Accounts payable and accrued expenses	1,416	2,430
Deferred revenue	18,277	17,826
Lease deposits and other obligations to tenants	26,641	18,539
Total liabilities	46,334	38,795
Total Medical Properties Trust, Inc. stockholders' equity	353,502	282,765
Total Liabilities and Equity	399,836	321,560
Total equity	353,502	282,765
Non-Guarantor Subsidiaries [Member]
Condensed Financial Statements, Captions [Line Items]
Land, buildings and improvements, and intangible lease assets	170,946	128,442
Gross investment in real estate assets	170,946	128,442
Accumulated depreciation and amortization	(13,091)	(10,327)
Net investment in real estate assets	157,855	118,115
Cash and cash equivalents	1,236	1,586	967		493
Interest and rent receivable	6,133	5,292
Straight-line rent receivable	9,445	7,732
Other loans	55,724	50,807
Net intercompany receivable (payable)	(34,499)	(29,320)
Other assets	16,256	11,554
Total Assets	212,150	165,766
Debt, net	54,086	8,433
Accounts payable and accrued expenses	411	403
Deferred revenue	4,696	4,875
Lease deposits and other obligations to tenants	1,129	1,618
Total liabilities	60,322	15,329
Total Medical Properties Trust, Inc. stockholders' equity	151,828	150,437
Total Liabilities and Equity	212,150	165,766
Total equity	151,828	150,437
Eliminations [Member]
Condensed Financial Statements, Captions [Line Items]
Cash and cash equivalents
Investment in subsidiaries	(1,343,429)	(1,333,151)
Total Assets	(1,343,429)	(1,333,151)
Total Medical Properties Trust, Inc. stockholders' equity	(1,343,329)	(1,333,037)
Non-controlling interests	(100)	(114)
Total Liabilities and Equity	(1,343,429)	(1,333,151)
Total equity	(1,343,429)	(1,333,151)
Total Consolidated [Member]
Condensed Financial Statements, Captions [Line Items]
Land, buildings and improvements, and intangible lease assets	1,258,288	1,032,369
Mortgage loans	165,000	165,000
Gross investment in real estate assets	1,423,288	1,197,369
Accumulated depreciation and amortization	(100,772)	(76,094)
Net investment in real estate assets	1,322,516	1,121,275
Cash and cash equivalents	114,368	98,408	$ 106,481		$ 15,307
Interest and rent receivable	28,822	26,176
Straight-line rent receivable	34,603	28,912
Other loans	56,131	50,985
Other assets	39,249	23,058
Total Assets	1,595,689	1,348,814
Debt, net	649,013	369,970
Accounts payable and accrued expenses	57,666	35,974
Deferred revenue	23,576	23,137
Lease deposits and other obligations to tenants	27,770	20,157
Total liabilities	758,025	449,238
Total Medical Properties Trust, Inc. stockholders' equity	837,564	899,462
Non-controlling interests	100	114
Total Liabilities and Equity	1,595,689	1,348,814
Total equity	$ 837,664	$ 899,576

Condensed Consolidating Financial Information (Summary Of Condensed Consolidated Statements Of Income) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Revenues
Rent billed	$ 30,738	$ 23,472	$ 88,519	$ 69,032
Straight-line rent	1,802	(1,124)	5,606	469
Interest and fee income	5,251	6,296	15,812	20,594
Total revenues	37,791	28,644	109,937	90,095
Expenses
Real estate depreciation and amortization	8,430	6,209	24,678	18,100
Impairment charge			564	12,000
Property-related	312	600	629	2,055
General and administrative	5,736	5,849	20,428	20,532
Acquisition expenses	530	364	3,186	1,314
Total operating expenses	15,008	13,022	49,485	54,001
Operating income (expense)	22,783	15,622	60,452	36,094
Other income (expense)
Interest income and other	51	1,475	58	1,488
Debt refinancing costs	(10,425)	(342)	(14,214)	(6,556)
Interest expense	(11,935)	(8,092)	(32,462)	(26,106)
Net other income (expense)	(22,309)	(6,959)	(46,618)	(31,174)
Income (loss) from continuing operations	474	8,663	13,834	4,920
Income (loss) from discontinued operations	(6)	301	141	7,463
Net income	468	8,964	13,975	12,383
Net income attributable to non-controlling interests	(43)	(45)	(131)	(63)
Net income (loss) attributable to MPT common stockholders	425	8,919	13,844	12,320
Parent [Member]
Expenses
General and administrative	18	(9)	62	74
Total operating expenses	18	(9)	62	74
Operating income (expense)	(18)	9	(62)	(74)
Other income (expense)
Income (loss) from continuing operations	(18)	9	(62)	(74)
Equity in earnings of consolidated subsidiaries net of income taxes	486	8,955	14,037	12,457
Net income	468	8,964	13,975	12,383
Net income attributable to non-controlling interests	(43)	(45)	(131)	(63)
Net income (loss) attributable to MPT common stockholders	425	8,919	13,844	12,320
Subsidiary Issuers [Member]
Revenues
Interest and fee income	1,351	1,420	4,118	5,561
Total revenues	1,351	1,420	4,118	5,561
Expenses
Property-related	87	(43)	87	5
General and administrative	6,348	5,781	18,356	20,216
Acquisition expenses	513	364	2,717	1,314
Total operating expenses	6,948	6,102	21,160	21,535
Operating income (expense)	(5,597)	(4,682)	(17,042)	(15,974)
Other income (expense)
Interest income and other	44	(17)	42
Debt refinancing costs	(10,425)	(342)	(14,109)	(6,556)
Interest expense	(11,735)	(8,058)	(31,750)	(25,706)
Net other income (expense)	(22,116)	(8,417)	(45,817)	(32,262)
Income (loss) from continuing operations	(27,713)	(13,099)	(62,859)	(48,236)
Equity in earnings of consolidated subsidiaries net of income taxes	28,199	22,054	76,896	60,693
Net income	486	8,955	14,037	12,457
Net income attributable to non-controlling interests	(43)	(45)	(131)	(63)
Net income (loss) attributable to MPT common stockholders	443	8,910	13,906	12,394
Subsidiary Guarantors [Member]
Revenues
Rent billed	26,608	20,116	76,907	59,011
Straight-line rent	1,255	(1,612)	3,891	(951)
Interest and fee income	4,000	4,216	12,677	12,621
Total revenues	31,863	22,720	93,475	70,681
Expenses
Real estate depreciation and amortization	7,455	5,421	21,914	15,740
Impairment charge			564
Property-related	211	640	513	2,020
Acquisition expenses	17		469
Total operating expenses	7,683	6,061	23,460	17,760
Operating income (expense)	24,180	16,659	70,015	52,921
Other income (expense)
Interest income and other	84	1,494	84	1,494
Interest expense	230	(5)	488	(33)
Net other income (expense)	314	1,489	572	1,461
Income (loss) from continuing operations	24,494	18,148	70,587	54,382
Income (loss) from discontinued operations		(154)	98	(561)
Equity in earnings of consolidated subsidiaries net of income taxes	1,112	1,073	3,457	3,201
Net income	25,606	19,067	74,142	57,022
Net income (loss) attributable to MPT common stockholders	25,606	19,067	74,142	57,022
Non-Guarantor Subsidiaries [Member]
Revenues
Rent billed	4,461	3,682	12,606	10,726
Straight-line rent	547	488	1,715	1,420
Interest and fee income	1,088	2,192	3,105	8,411
Total revenues	6,096	6,362	17,426	20,557
Expenses
Real estate depreciation and amortization	975	788	2,764	2,360
Impairment charge				12,000
Property-related	345	329	1,023	735
General and administrative	(630)	77	2,010	242
Total operating expenses	690	1,194	5,797	15,337
Operating income (expense)	5,406	5,168	11,629	5,220
Other income (expense)
Interest income and other	(77)	(2)	(68)	(6)
Debt refinancing costs			(105)
Interest expense	(1,618)	(1,561)	(5,288)	(6,366)
Net other income (expense)	(1,695)	(1,563)	(5,461)	(6,372)
Income (loss) from continuing operations	3,711	3,605	6,168	(1,152)
Income (loss) from discontinued operations	(6)	455	43	8,024
Net income	3,705	4,060	6,211	6,872
Net income (loss) attributable to MPT common stockholders	3,705	4,060	6,211	6,872
Eliminations [Member]
Revenues
Rent billed	(331)	(326)	(994)	(705)
Interest and fee income	(1,188)	(1,532)	(4,088)	(5,999)
Total revenues	(1,519)	(1,858)	(5,082)	(6,704)
Expenses
Property-related	(331)	(326)	(994)	(705)
Total operating expenses	(331)	(326)	(994)	(705)
Operating income (expense)	(1,188)	(1,532)	(4,088)	(5,999)
Other income (expense)
Interest expense	1,188	1,532	4,088	5,999
Net other income (expense)	1,188	1,532	4,088	5,999
Equity in earnings of consolidated subsidiaries net of income taxes	(29,797)	(32,082)	(94,390)	(76,351)
Net income	(29,797)	(32,082)	(94,390)	(76,351)
Net income attributable to non-controlling interests	43	45	131	63
Net income (loss) attributable to MPT common stockholders	(29,754)	(32,037)	(94,259)	(76,288)
Total Consolidated [Member]
Revenues
Rent billed	30,738	23,472	88,519	69,032
Straight-line rent	1,802	(1,124)	5,606	469
Interest and fee income	5,251	6,296	15,812	20,594
Total revenues	37,791	28,644	109,937	90,095
Expenses
Real estate depreciation and amortization	8,430	6,209	24,678	18,100
Impairment charge			564	12,000
Property-related	312	600	629	2,055
General and administrative	5,736	5,849	20,428	20,532
Acquisition expenses	530	364	3,186	1,314
Total operating expenses	15,008	13,022	49,485	54,001
Operating income (expense)	22,783	15,622	60,452	36,094
Other income (expense)
Interest income and other	51	1,475	58	1,488
Debt refinancing costs	(10,425)	(342)	(14,214)	(6,556)
Interest expense	(11,935)	(8,092)	(32,462)	(26,106)
Net other income (expense)	(22,309)	(6,959)	(46,618)	(31,174)
Income (loss) from continuing operations	474	8,663	13,834	4,920
Income (loss) from discontinued operations	(6)	301	141	7,463
Net income	468	8,964	13,975	12,383
Net income attributable to non-controlling interests	(43)	(45)	(131)	(63)
Net income (loss) attributable to MPT common stockholders	$ 425	$ 8,919	$ 13,844	$ 12,320

Condensed Consolidating Financial Information (Summary Of Condensed Consolidated Statements Of Cash Flows) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010	Dec. 31, 2010
Operating activities
Net income	$ 468	$ 8,964	$ 13,975	$ 12,383
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization			25,254	19,634
Straight-line rent revenue			(5,606)	(587)
Share/Unit-based compensation			5,293	5,250
Gain on sale of real estate			(5)	(7,693)
Impairment			564	12,000
Increase (decrease) in accounts payable and accrued liabilities			13,317	2,899
Amortization and write-off of deferred financing costs and debt discount			8,523	4,961
Premium paid on extinguishment of debt			13,091	3,834
Other adjustments			(7,278)	(5,188)
Net cash provided by (used in) operating activities			67,128	47,493
Investing activities
Real estate acquired			(196,511)	(73,851)
Principal received on loans receivable			2,898	46,532
Proceeds from sale of real estate				75,000
Investment in loans receivable and other investments			(16,800)	(9,626)
Construction in progress and other			(12,297)	(15,578)
Net cash provided by (used in) investing activities			(222,710)	22,477
Financing activities
Revolving credit facilities, net			39,600	(137,200)
Additions to term debt			450,000	148,500
Payments of term debt			(237,810)	(216,325)
Distributions paid			(67,194)	(54,761)
Sale of common stock/units, net				288,470
Lease deposits and other obligations to tenants			7,613	2,233
Debt issuance costs paid and other financing activities			(20,667)	(9,713)
Net cash provided by financing activities			171,542	21,204
Increase in cash and cash equivalents for period			15,960	91,174
Cash and cash equivalents at beginning of period			98,408	15,307	$ 15,307
Cash and cash equivalents at end of period	114,368	106,481	114,368	106,481	98,408
Parent [Member]
Operating activities
Net income	468	8,964	13,975	12,383
Adjustments to reconcile net income to net cash provided by operating activities
Net cash provided by (used in) operating activities			(124)	(1,885)
Investing activities
Real estate acquired
Principal received on loans receivable
Proceeds from sale of real estate
Investments in and advances to subsidiaries			67,126	(231,996)
Investment in loans receivable and other investments
Construction in progress and other
Net cash provided by (used in) investing activities			67,126	(231,996)
Financing activities
Revolving credit facilities, net
Additions to term debt
Payments of term debt
Distributions paid			(67,002)	(54,589)
Sale of common stock/units, net				288,470
Lease deposits and other obligations to tenants
Debt issuance costs paid and other financing activities
Net cash provided by financing activities			(67,002)	233,881
Increase in cash and cash equivalents for period
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Subsidiary Issuers [Member]
Operating activities
Net income	486	8,955	14,037	12,457
Adjustments to reconcile net income to net cash provided by operating activities
Net cash provided by (used in) operating activities			(26,727)	(19,512)
Investing activities
Real estate acquired
Principal received on loans receivable
Proceeds from sale of real estate
Investments in and advances to subsidiaries			(89,763)	49,874
Investment in loans receivable and other investments			(205)
Construction in progress and other				(13)
Net cash provided by (used in) investing activities			(89,968)	49,861
Financing activities
Revolving credit facilities, net				(96,000)
Additions to term debt			450,000	148,500
Payments of term debt			(229,271)	(216,145)
Distributions paid			(67,194)	(54,761)
Sale of common stock/units, net				288,470
Lease deposits and other obligations to tenants
Debt issuance costs paid and other financing activities			(20,530)	(9,713)
Net cash provided by financing activities			133,005	60,351
Increase in cash and cash equivalents for period			16,310	90,700
Cash and cash equivalents at beginning of period			96,822	14,814	14,814
Cash and cash equivalents at end of period	113,132	105,514	113,132	105,514	96,822
Subsidiary Guarantors [Member]
Operating activities
Net income	25,606	19,067	74,142	57,022
Adjustments to reconcile net income to net cash provided by operating activities
Impairment			564
Net cash provided by (used in) operating activities			86,972	68,429
Investing activities
Real estate acquired			(168,600)	(73,851)
Principal received on loans receivable
Proceeds from sale of real estate
Investments in and advances to subsidiaries			89,135	8,711
Investment in loans receivable and other investments			(3,314)	(5,000)
Construction in progress and other			(12,297)	(1,607)
Net cash provided by (used in) investing activities			(95,076)	(71,747)
Financing activities
Revolving credit facilities, net
Additions to term debt
Payments of term debt
Distributions paid
Sale of common stock/units, net
Lease deposits and other obligations to tenants			8,104	3,318
Debt issuance costs paid and other financing activities
Net cash provided by financing activities			8,104	3,318
Increase in cash and cash equivalents for period
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Non-Guarantor Subsidiaries [Member]
Operating activities
Net income	3,705	4,060	6,211	6,872
Adjustments to reconcile net income to net cash provided by operating activities
Impairment				12,000
Net cash provided by (used in) operating activities			7,007	461
Investing activities
Real estate acquired			(27,911)
Principal received on loans receivable			2,898	46,532
Proceeds from sale of real estate				75,000
Investments in and advances to subsidiaries			504	(60,470)
Investment in loans receivable and other investments			(13,281)	(4,626)
Construction in progress and other				(13,958)
Net cash provided by (used in) investing activities			(37,790)	42,478
Financing activities
Revolving credit facilities, net			39,600	(41,200)
Additions to term debt
Payments of term debt			(8,539)	(180)
Distributions paid
Sale of common stock/units, net
Lease deposits and other obligations to tenants			(491)	(1,085)
Debt issuance costs paid and other financing activities			(137)
Net cash provided by financing activities			30,433	(42,465)
Increase in cash and cash equivalents for period			(350)	474
Cash and cash equivalents at beginning of period			1,586	493	493
Cash and cash equivalents at end of period	1,236	967	1,236	967	1,586
Eliminations [Member]
Operating activities
Net income	(29,797)	(32,082)	(94,390)	(76,351)
Adjustments to reconcile net income to net cash provided by operating activities
Net cash provided by (used in) operating activities
Investing activities
Real estate acquired
Principal received on loans receivable
Proceeds from sale of real estate
Investments in and advances to subsidiaries			(67,002)	233,881
Investment in loans receivable and other investments
Construction in progress and other
Net cash provided by (used in) investing activities			(67,002)	233,881
Financing activities
Revolving credit facilities, net
Additions to term debt
Payments of term debt
Distributions paid			67,002	54,589
Sale of common stock/units, net				(288,470)
Lease deposits and other obligations to tenants
Debt issuance costs paid and other financing activities
Net cash provided by financing activities			67,002	(233,881)
Increase in cash and cash equivalents for period
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Total Consolidated [Member]
Operating activities
Net income	468	8,964	13,975	12,383
Adjustments to reconcile net income to net cash provided by operating activities
Impairment			564	12,000
Net cash provided by (used in) operating activities			67,128	47,493
Investing activities
Real estate acquired			(196,511)	(73,851)
Principal received on loans receivable			2,898	46,532
Proceeds from sale of real estate				75,000
Investment in loans receivable and other investments			(16,800)	(9,626)
Construction in progress and other			(12,297)	(15,578)
Net cash provided by (used in) investing activities			(222,710)	22,477
Financing activities
Revolving credit facilities, net			39,600	(137,200)
Additions to term debt			450,000	148,500
Payments of term debt			(237,810)	(216,325)
Distributions paid			(67,194)	(54,761)
Sale of common stock/units, net				288,470
Lease deposits and other obligations to tenants			7,613	2,233
Debt issuance costs paid and other financing activities			(20,667)	(9,713)
Net cash provided by financing activities			171,542	21,204
Increase in cash and cash equivalents for period			15,960	91,174
Cash and cash equivalents at beginning of period			98,408	15,307	15,307
Cash and cash equivalents at end of period	$ 114,368	$ 106,481	$ 114,368	$ 106,481	$ 98,408